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ABSTRACT
Ergot alkaloids are fungal-derived secondary metabolites well known for a
diverse array of pharmacological effects both beneficial and detrimental to human health.
Historically, the ergot alkaloids have been known to cause ergotism in populations that
consume grain contaminated by ergot alkaloid producing fungus. However, naturally
isolated and semi-synthetic derivatives of certain ergot alkaloids have also been used to
treat migraines, Parkinsonism, and tumor growth.
Different fungal species such as Aspergillusfumigatus, Claviceps purpurea, and
Neotyphodium lolii produce ergot alkaloids that have distinct structural features yet share
a common tetracyclic ergoline ring scaffold. Mechanistic details regarding the formation
of the common ergoline ring are not well understood, though the genes encoding the
enzymes that carry out these cyclizations are believed to be well conserved across
divergent fungal species. Here we describe in vivo gene disruption experiments in
Aspergillusfumigatus that allowed us to identify candidate enzymes that were directly
involved with the intramolecular cyclization of the ergoline ring. Additionally, we
discuss the cloning and heterologous expression of these genes to further characterize
their catalytic function.
Old Yellow Enzyme homologues from the ergot gene clusters of Aspergillus
fumigatus and Neotyphodium loii were shown to catalyze the formation of the D ring of
the ergoline skeleton. These enzymes catalyzed either reductase or isomerase type
reactions to yield distinct pathway intermediates. Mutational analysis was used to
engineer an Old Yellow Enzyme that displayed both reductase and isomerase activities,
thereby elucidating the mechanistic basis behind this switch in enzymatic activity. These
findings present a mechanistic rationale behind nature's biosynthetic strategy toward ring
cyclization and the introduction of structural diversity into the ergot alkaloid class of
natural products.
Thesis Supervisor: Sarah E. O'Connor
Title: Associate Professor of Chemistry
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Chapter 1 . Background and Significance
Historical Significance of Ergot Alkaloids
Ergot alkaloids are formed in sclerotia, a dark dense mass of fungal mycelium,
produced upon the infection of grass and grains by parasitic fungi of the genus Claviceps.
These compounds are also produced in a variety of other fungi, including the genera
Aspergillus and Neotyphodium.' Ergot alkaloids have long been a part of human history.
Ergot has been documented for use in obstetrics as early as 1100 BC in China. Both ergot
grain disease and their bioactive properties have also been noted throughout Egyptian,
Assyrian, and Greek history.2 Ergot alkaloids rose to notoriety during the Middle Ages in
Central Europe being the cause of mass poisonings in both humans and animals which
fed on grass or grains that were contaminated by ergot producing fungi. 3 Symptoms
included gangrene, convulsions, and hallucination, that were collectively known as "St.
Anthony's Fire" or "Ergotism". Ergot alkaloids were also associated with historical
events of mass hysteria during the Great Fear of the French Revolution as well as the
Salem Witch Trials.1,2
It was not until the latter part of the 17th century, when ergotism was finally
correlated to the consumption of infected rye containing ergot alkaloids, increased human
awareness and knowledge reduced these mass poisonings. The use of ergot compounds in
modem western medicine for post partum hemorrhage occurred in the early 19th century.
Further research and screening of ergot derivatives for oxytocic activity in 1938 resulted
in the synthesis of lysergic acid diethylamide (LSD) hallucinogen that has since become
infamous for its use as an illicit recreational drug.2
The notorious history and abuse of ergot compounds have often overshadowed its
beneficial medicinal properties. In present times, ergot alkaloids are the inspiration for
numerous semi-synthetic derivatives that have been applied for a wide range of medicinal
purposes including the treatment of migraines, parkinsonism, and tumor growth. The
diverse bioactivity exhibited by ergot alkaloids is related to its ability to act as an agonist
or antagonist toward neuroreceptors for dopamine, serotonin, and adrenaline.4'5 Semi-
synthetic derivatives of ergot alkaloids aim to tailor their activity toward specific
receptors while reducing their adverse side effects (Figure 1.1). A number of previous
studies have yielded insight into the structure activity relationships of the ergot
alkaloids.'" Ergot alkaloids remain a valuable resource to be fully explored for novel
pharmaceutical analogs.
Ergot Alkaloid Classes
All naturally produced ergot alkaloid structures are composed of the tetracyclic
ergoline ring (Figure 1.2A). Ergot alkaloids may be divided into classes based on the
substituents that are attached on the ergoline scaffold; these include the clavines, simple
lysergic acid derivatives, and ergopeptides." The clavines include such structures which
are all hydroxy and dehydro versions of the 6,8-dimethylergoline structure (Figure
1.2B). Simple lysergic acid derivatives consist of an attached alkyl amide or small
peptide (Figure 1.2C). Ergopeptides consists of a D-lysergic acid and a cyclic tripeptide
moiety (Figure 1.2D).
Figure 1.1. Ergot alkaloid natural products and semi-synthetic derivatives displaying
diverse bioactivity by interactions with different neurotransmitter receptors. The
tetracyclic ergoline ring common to all ergot alkaloids is shown in red.
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Figure 1.2. A. 6,8-dimethylergoline tetracyclic ring structure. Conventional ergoline ring
numbering and lettering are designated for each ring. B. Clavines include hydroxy and
dehydro versions of the 6,8-dimethylergoline structure. C. Simple lysergic acid
derivatives consist of the basic D-lysergic acid structure with attachment of an amide in
the form of an alkyl amide or small peptide. D. Ergopeptides consists of a D-lysergic acid
with a cyclic tripeptide moiety.
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Ergot Alkaloid Producers
Ergot alkaloid producing fungi occupy distinct ecological niches,
Clavicipitaceous species such as Claviceps purpurea and Neotyphodium lolii from the
order Eurotiales are plant parasites, while Aspergillusfumigatus from the order
Hypocreales is an opportunistic pathogen of mammals. 1,12-14 These distantly related
fungal lineages produce unique ergot alkaloid profiles.
Ergot alkaloids that are derivatives of lysergic acid and ergopeptides (Figure 1.2
C, D) are associated with Clavicipitaceous fungi Claviceps purpurea and Neotyphodium
lolii, and are believed to aid in protecting the fungi from predation by mammals. By
contrast, fumigaclavine ergot alkaloids are only produced by A. fumigatus during
conidiation, though their biological role to aid in survival of conidia during invasive
aspergillosis is not completely understood.1 ' 15
A unique quality to fungal genes coding for the biosynthesis of secondary
metabolites is their clustering on a single genetic locus. In contrast, genes for primary
metabolism are not localized in clusters.12 For fungi the clustering of genes for secondary
metabolite production are believed to improve efficiency of gene regulation and thereby
confer selective advantage. Other hypotheses postulate that this clustering may be a result
of horizontal gene transfer from prokaryotes.
12
, 16
The ergot alkaloid biosynthetic genes are clustered in A. fumigatus 14'17 as well as
Clavicipitaceous fungi C. purpurea '8 ,19 and N. lolii.2 0 ,2 1 Shared gene homologues
between A. fumigatus, C. purpurea, and N. lolii are believed to participate in early steps
of ergot biosynthesis, while species-unique genes are responsible for downstream
modifications to yield either fumigaclavines in A. fumigatus or ergopeptides / lysergic
acid derivatives in Clavicipitaceous fungi (Figure 1.3). 1, 14, 22-24 Therefore, it is believed
that the distantly related A. fumigatus and Clavicipitaceous fungi share a common origin
for their ability to produce ergot alkaloids (Figure 1.3). A notable difference between
these ergot alkaloid classes is the fully saturated D ring of the ergoline (Figure 1.2A)
structure found in the clavine type alkaloids from A. fumigatus. In contrast, ergot
alkaloids of Clavicipitaceous fungi C. purpurea and N. lolii, have an unsaturated
ergoline D ring.2 5 More information regarding the early and late step genes of ergot
alkaloid biosynthetic clusters are presented in the following sections.
Figure 1.3. Early biosynthetic pathway steps are proposed to be conserved across
divergent fungi. Later biosynthetic pathway steps create diverse ergot alkaloid profiles in
different fungal species. Clavicipitaceous fungi C. purpurea and N. lolii are associated
with production of ergot alkaloids with an unsaturated ergoline D ring. A. fumigatus is
associated with the production of ergot alkaloids with a saturated ergoline D ring.
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Ergot Alkaloid Biosynthesis
Proposed Ergot Alkaloid Biosynthetic Pathway
Much of the early pathway of ergot alkaloid biosynthesis had been investigated
through extensive isotope feeding studies with cultures of C. purpurea.26 -38 These studies
were instrumental in proposing a biosynthetic pathway for ergot compounds (Figure 1.4).
The first committed step in ergot alkaloid biosynthesis is the prenylation of L-tryptophan
1 with dimethylallyl pyrophosphate (DMAPP) 2, to yield 4-dimethylallyl-L-tryptophan
(DMAT) 3. The next step involves the N-methylation of DMAT 3 to yield 4-dimethyl-L-
abrine (N-Me-DMAT) 4.38 Subsequently, a proposed series of successive oxidation steps
catalyze the intramolecular cyclization of the prenyl and indole moieties to form ring C in
tricyclic chanoclavine-I 6. Chanoclavine-I 6 in turn is oxidized to form chanoclavine-I-
aldehyde 7, which is the last common precursor of ergot alkaloid producing fungi prior to
pathway divergence. At this branch point of ergot alkaloid pathways, chanoclavine-I-
aldehyde 7 undergoes another intramolecular cyclization resulting in the formation of
ring D of tetracyclic agroclavine 10 (C. purpurea, N.lolii) or festuclavine 11 (A.
fumigatus).1, s,2 s Thereafter, the pathway diverges where agroclavine 10 and festuclavine
11 are further derived into respective lysergic acid amides/peptides and fumigaclavines
(Figure 1.3).39-43 Many of the enzymes associated with each of these pathway steps were
found to be encoded by ergot alkaloid biosynthetic gene clusters in divergent fungal
species.
Figure 1.4. Proposed early steps of ergot alkaloid biosynthesis up to chanoclavine-I-
aldehyde 7. Later pathway steps diverge to give either agroclavine 10 or festuclavine 11
derived ergot alkaloids in different fungal species. Solid arrows represent biosynthetic
steps that have been studied in vitro and are associated with the corresponding enzyme
homologs (red) encoded by the ergot gene clusters. Dashed arrows represent proposed
steps that are not well understood but associated with the remaining ergot cluster genes
encoding oxidases EasC and EasE. Brackets represent hypothetical cyclized iminium 8, 9
intermediates.
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Ergot Alkaloid Biosynthetic Gene Clusters
The ergot biosynthetic gene clusters of A. fumigatus, C. purpurea, and N. lolii
share a set of homologues that are associated to early pathway ergot alkaloid biosynthesis
(Figure 1.5). These conserved set of homologous genes across divergent fungal species
are attributed to the early steps of ergoline biosynthesis from the prenylation of L-
tryptophan 1 up to the cyclization of ring D (Figure 1.4). 14
The first determinant step for entry into the ergot biosynthetic pathway is
catalyzed by the 4-dimethylallyl prenyltransferase (DmaW) enzyme purified to
homogeneity from cultures of ergot alkaloid producing C. fusiformis (formerly annotated
as Clavicepspurpurea).3 It was shown to prenylate L-tryptophan 1 via an electrophilic
aromatic substitution mechanism. 32 Using a reverse genetics approach, the group of Tsai
et al. successfully identified and cloned the gene coding for L-tryptophan dimethylallyl
prenyl transferase (DmaW) from C. fusiformis. Eventually this allowed the identification
of other ergot alkaloid biosynthetic genes from C. purpurea via chromosome walking.' 8'
19
The C. purpurea gene cluster for ergotamine 12 biosynthesis (68.5kb) was
identified by the Tudzynski group (Figure 1.5B). 18'19 Gene open reading frames were
assigned putative functions based on sequence similarity to previously characterized
enzymes.'8 Importantly, this gene cluster included a homologue of dmaW
prenyltransferase and open reading frames encoding the non-ribosomal peptide
synthetase (NRPS) module and lysergylpeptidyl synthetase 1 and 2 (Lps] and Lps2)
genes that are involved with the later biosynthetic pathway formation of ergopeptides
(Figure 1.6).39,42,44 Additionally it was observed that comparison of cluster sequences
within C. purpurea strain P1 (ergotamine producer) with strain C. purpurea ECC93
(ergocristine producer) displayed conservation of most genes associated with the early
pathway formation of the ergoline ring, yet displayed high variation in genes associated
with the NRPS production of the peptide ergot moiety.' 8 These observations supported
the hypothesis that clustered early pathway genes are responsible for similar steps of
biosynthesis of the ergoline ring, while variations in genes encoding the later step NRPS
modules confer intraspecies diversification of peptide ergot alkaloids.
Clustered genes for ergot biosynthesis in a different fungal species Neotyphodium
sp. Lpl (a natural hybrid Neotyphodium lolii x Epichloe typhina) were initially studied by
Panaccione et al., where disruption of the Lpsl homologue (LpsA) involved in
ergopeptide biosynthesis resulted in the loss of downstream alkaloid ergovaline 13.41,45
In another gene knockout experiment with Neotyphodium sp. Lpl, Wang et al.
demonstrated that disruption of a dmaW homologue led to loss of ergovaline 13
production. 20 Complementation of the gene with the dmaWhomologue from C.
fusiformis restored ergot alkaloid production. 20,45 Later, the Fleetwood group of
identified part of the ergot alkaloid cluster for ergovaline 13 biosynthesis (~ 9kb) in N.
lolli using both chromosome walking and southern blot (Figure 1.5D).21 Again it was
noted that genes associated with the early steps of ergoline biosynthesis were conserved
across other ergot producing fungal species, while later pathway genes were divergent.
Notably, it was demonstrated that the LpsB gene in N. lolii, a homologue of the C.
purpurea Lps2 in ergotamine 12 synthesis, was associated with ergovaline 13
production.2 1 This observation again reinforced the hypothesis that the biosynthesis of
the ergoline ring is encoded by a set of conserved genes, while later pathway genes are
divergent across different fungal species, creating the resulting diversity in ergot alkaloid
profiles.
The A. fumigatus ergot biosynthetic gene cluster is associated to the production of
fumigaclavines and festuclavine 11 14. The gene cluster that is responsible for the
production of these ergot alkaloids had been previously identified via gene disruption of
dmaW in A. fumigatus and heterologous expression and characterization of the
dimethylallyltryptophan synthase dma W gene (annotated as fgaPT2) in Saccharomyces
cerevisiae.14' 17 The extension of this dmaW sequence information allowed identification
of the biosynthetic cluster for fumigaclavine C 14 (22kb) of A. fumigatus (Figure 1.5A).
Further analysis of gene function in this cluster led to the characterization of easF and
easD gene products that are attributed to the early step ergot pathway. 46' 4 7 This cluster
again contained a set of genes, homologous with the other known Clavicipitaceous fungal
species C. purpurea and N. lolii, that were likely to be associated with the early ergot
alkaloid synthetic pathway. Notably, no homologues for the later pathway lysergyl
peptide synthase genes were observedis,21 correlating with the fact that A. fumigatus
does not produce lysergic acid derived ergopeptides. Instead the A. fumigatus gene cluster
displayed unique genes that were later shown to be associated with the decoration of the
fumigaclavine structure. Some of these downstream ergot pathway genes from A.
fumigatus have been cloned, expressed, and functionally characterized in the
40,43transformation of festuclavine 11 into fumigaclavine C 14 (Figure 1.6).
In summary, when comparing the ergot biosynthetic gene clusters of A. fumigatus
to the Clavicipitaceous fungi C. purpurea and N. lolii, the shared set of homologous
genes that are associated with early pathway ergot biosynthesis are conserved (Figure
1.5). This set of genes was attributed to the early steps of ergoline biosynthesis up to the
cyclization of the D ring (Figure 1.3). 14 In contrast, the genes that are unique to A.
fumigatus are proposed to be responsible for further decoration of festuclavine 11 to give
fumigaclavine C 14, while genes that are unique to Clavicipitaceous fungi such as C.
purpurea and N. loli are involved with the transformation of agroclavine 10 to the
respective ergopeptides ergotamine 12 and ergovaline 13 (Figure 1.3). Notably, the
availability of this gene sequence information expedited the successful cloning and
functional characterization of ergot biosynthetic enzymes from A. fumigatus, C. purpurea
and N. lolii. 17,20,48
~1
Figure 1.5. Proposed ergot alkaloid biosynthetic gene clusters.
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Functional Characterization of Early Ergot Alkaloid Biosynthetic Enzymes
A number of genes in the ergot alkaloid biosynthetic clusters have been
previously studied yielding insight into the function of their associated gene products.
The first determinant step for entry into the ergot biosynthetic pathway is catalyzed by
the dimethylallyl prenyltransferase (DmaW), which has been purified to homogeneity
from cultures of ergot alkaloid producing C. fusiformis.3 1 DmaW was shown to prenylate
L-tryptophan 1 via electrophilic aromatic substitution.32 DmaW homologues from A.
fumigatus and other Clavicipitaceous fungi such as C. purpurea and N. lolii have also
been characterized.17, 20, 48
The next early pathway enzyme EasF is responsible for the N-methylation of
DMAT 3 and was first purified by Otsuka et al. from cell free cultures of C. purpurea.38
EasF displayed activity for methylating the amine nitrogen of dimethylallyl tryptophan
with the S-adenosyl methionine (SAM) co-factor. Later, with the identification of the
ergot biosynthetic gene cluster in A. fumigatus, the easF gene was successfully cloned
and heterologously expressed. EasF displayed the predicted N-methyltransferase activity,
yielding N-Me-DMAT 4 (dimethylallyl L-abrine) from DMAT 3.47
Following the N-methyltransferase EasF, two successive oxidations are proposed
to transform N-Me-DMAT 4 to chanoclavine-I 6 thus forming ergoline ring C. These two
oxidation steps of the pathway are predicted based on feeding studies conducted by Floss
et al.30'33 Two notable observations from these studies were (1) observation that a
proposed diene intermediate 5 was incorporated into downstream ergot alkaloids of C.
purpurea34 and (2) molecular oxygen was incorporated into chanoclavine-I 6. Enzyme
candidates of the ergot clusters that were capable of carrying out oxidation reactions were
proposed to be EasC and EasE, which display protein sequence similarity to other
catalases and FAD oxygenases, respectively. The involvement of the easE gene product
in the oxidations of N-Me-DMAT 4 to chanoclavine-I 6 in C. purpurea has also been
demonstrated by gene disruption experiments.5 0 Details regarding the function of EasC
and EasE and their putative role in carrying out the formation of ring C are not well
understood and were one of the focuses of our research efforts (Chapter 5).
The next enzyme of the ergot pathway, EasD, is an NAD* binding oxidase
capable of oxidizing the hydroxyl group of chanoclavine-I 6 to yield chanoclavine-I-
aldehyde 7. EasD was successfully cloned and characterized from A. fumigatus by
Wallwey et al.46
The next enzymes of the pathway, EasA and EasG, are required for the
cyclization of chanoclavine-I-aldehyde 7 to form ergoline ring D, representing the
branching point of ergot alkaloid biosynthesis into either festuclavine 11 (A. fumigatus)
or agroclavine 10 derived alkaloids (C. purpurea / N. loifi). Homologues of EasA in the
ergot cluster show protein sequence similarity to enzymes of the Old Yellow Enzyme
(OYE) family. OYE enzymes display activity toward the reduction of a, p-unsaturated
ketones and aldehydes.5 1 ,52 Therefore, EasA served as a likely candidate capable of
reducing the a, p-unsaturated carbon-carbon double bond of chanoclavine-I-aldehyde 7 to
yield the hypothetical cyclized iminium intermediates 8 and 9 toward ring D formation
(Figure 1.4). The EasG protein encoded by the gene cluster displays similarity to
Rossmann fold NADPH reductases5'54, and its likely function is to reduce the proposed
cyclized iminium products 8 and 9 of EasA to form agroclavine 10 (C. purpurea / N.
loii) or festuclavine 11 (A. fumigatus) respectively. The details of EasA and EasG
function, mechanism, and role in cyclization of the D ring in diverse fungal species were
not fully understood and served as the focus of our study (Chapters 3 and 4).
Functional Characterization of Late Ergot Alkaloid Biosynthetic Enzymes
Early pathway steps establish the ergoline ring up to either the festuclavine 11 or
agroclavine 10 intermediate compound. The enzymes involved with the transformations
in later step ergot alkaloid pathway biosynthesis are attributed to the pathway divergence
of ergot alkaloid profiles observed in different fungal species. The Clavicipitaceous fungi
C. purpurea and N. lolii carry late step pathway genes encoding non-ribosomal peptide
synthases (NRPS) domains for the conversion of agroclavine 10 into ergopeptides.
Several of these genes have been studied by gene disruption or in vitro characterization
(Figure 1.6).21,42, 44,49, 5 These studies have shown evidence that ergopeptide formation
occurs via an enzyme complex composed of NRPS subunits D-lysergyl peptidyl
synthetase (Lps2) that activates D-lysergic acid 15 and (Lpsl) which in turn activates
amino acids alanine, phenylalanine, and proline to form the tripeptide moiety.42 The
enzyme CloA was also demonstrated to be critical for the oxidation of elymoclavine 16 to
yield paspalic acid 17, which either spontaneously or via an isomerase enzyme rearranges
to form D-lysergic acid 15. Previously, a proposed p450 monooxygenase from a
microsomal fraction of Claviceps has also been observed to convert agroclavine 10 to
elymoclavine 16 (Figure 1.6).56, 57
In contrast, the A. fumigatus fumigaclavine C 14 biosynthetic gene cluster carries
late ergot pathway genes that have been demonstrated to show acetylation and reverse
prenyl transferase activities for the conversion of festuclavine 11 into later pathway
fumigaclavine A 18, fumigaclavine B 19, and fumigaclavine C 14.17,40,43,46 Notably, A.
fumigatus does not carry any genes that encode for NRPS domains that are observed in
ergot biosynthetic clusters of N. loli and C. purpurea (Figure 1.6).
Figure 1.6. Late step ergot biosynthetic pathway showing agroclavine 10 derived
alkaloid ergotamine 12 (C. purpurea) and festuclavine 11 derived alkaloid fumigaclavine
C 14 (A. fumigatus). Enzymes associated with synthesis of ergotamine 12 (red) and
fumigaclavine C 14 (blue) that have been identified via gene disruption or in vitro
characterization. Dashed boxes represent putative enzymes necessary to carry out the
respective biosynthetic step.
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Research goal and thesis overview
I. Assign function to the conserved genes of the ergot alkaloid biosynthetic pathway
that are critical for the cyclization of rings C and D found in all ergot alkaloids.
Divergent ergot producing fungal species share a common set of gene
homologues associated with the early pathway biosynthesis of the ergoline ring, the
defining feature common to all ergot alkaloids. Yet, at the outset of this research, the
genes associated with the critical intramolecular cyclizations to form ergoline ring C and
D remained to be identified in the ergot biosynthetic cluster. Chapter 2 describes the
systematic disruption of genes associated with early ergot biosynthesis in A. fumigatus.
The subsequent interpretation of the resulting ergot alkaloid profiles of each A. fumigatus
mutant yielded valuable insight towards identifying the genes responsible for ring C and
D formation. The results from these experiments allowed heterologous expression and
functional characterization of enzymes involved in the cyclization of ring D (Chapter 3
and 4) and a putative catalase that facilitates formation of ring C (Chapter 5).
II. Obtain mechanistic insight into the enzymes involved with the intramolecular
cyclizations that are essential for formation of the ergoline ring C and D.
Details of ring C and D formation at the enzymatic level have only remained
speculative from a combination of previous feeding studies and gene knockout
experiments (Figure 1.4). To yield mechanistic insight into the formation of ergoline ring
C, Chapter 5 describes our efforts to study enzymes EasC and EasE. Purification of EasC
yielded a protein with catalase activity that allowed us to refine our hypothesis regarding
ergoline ring C formation.
To gain insight into ring D formation, Chapter 3 describes the cloning,
heterologous expression, and characterization of the enzymes EasA and EasG from A.
fumigatus involved with the formation of ergoline ring D of festuclavine 11. From this
study a mechanism for ergoline ring D cyclization was proposed for the formation of
festuclavine 11 from chanoclavine-I-aldehyde 7. This study also provided new
information on how EasA, an Old Yellow Enzyme homologue, plays a biosynthetic role
in ergot producing fungi.
III. Investigate the origin of ergot alkaloid structural divergence across different
fungal species.
Ergot alkaloid profiles of diverse fungi exhibit either agroclavine 10 derived
alkaloids (C. purpurea, N. lolii) or festuclavine 11 derived alkaloids (A. fumigatus). Prior
to the cyclization of ring D, the last common precursor across divergent fungi is proposed
to be chanoclavine-I-aldehyde 7 (Figure 1.3). In Chapter 4 we describe the study of an
EasA homologue from N. loii and its role in the cyclization of ring D to produce
agroclavine 10 as opposed to the EasA homologue from A. fumigatus which forms
festuclavine 11 described in Chapter 3. In addition, by using mutational analysis we
investigated the mechanistic rationale behind this critical branch point in ergot alkaloid
biosynthesis and created an EasA homologue capable of producing both festuclavine 11
and agroclavine 10 products. This study suggests that the EasA homologue found in
diverse ergot producing fungi of different origins exerts control over the formation of
festuclavine 11 or agroclavine 10 derived alkaloids. This study provided insight into the
mechanistic origin of ergot alkaloid pathway divergence.
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Step Ergot Alkaloid Biosynthesis
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Introduction
Fungal genes involved in the biosynthesis of secondary metabolites were known
to be clustered on a single genetic locus; in contrast, genes associated with primary
metabolism were not localized in a cluster.' We observe clustering of the ergot
biosynthetic genes in A. fumigatus2,3 as well as Clavicipitaceous fungi such as C.
purpurea4'5 and N. lolii 6 ,7(Figure 1.5). Shared homologous genes in the clusters of these
divergent fungi were associated with the early steps of ergot alkaloid biosynthesis
forming the tetracyclic ergoline ring.
Gene disruption has been a useful in vivo approach for assigning functions of
clustered ergot biosynthetic genes.6-9 The function of a particular gene is deduced by
monitoring accumulation of proposed pathway intermediates along with the
disappearance of downstream products in the gene disruption mutant strain. These results
were usually reflective of the reaction step catalyzed by the in vitro purified gene
product, which can be assayed after cloning and heterologous expression of the target
gene. For instance, in previous studies, gene disruption of the dmaW 4-dimethylallyl
prenyltransferase gene in A. fumigatus and N. lolii eliminated downstream ergot alkaloid
products that were observed in the wild type strains. 7'8 These results complemented the
observation that heterologously expressed DmaW was involved in the first determinant
step of ergot alkaloid biosynthesis via the prenylation of L-tryptophan 1.3 Therefore, in
vivo gene disruption is an important approach toward assigning gene function when used
in combination with in vitro gene product characterization.
At the outset of this research the only gene of early ergot alkaloid biosynthesis
that had been functionally characterized was dmaW.3' 7' 8 In contrast, characterization of
the other clustered genes responsible for encoding the enzymes involved with the critical
C and D ring cyclizations of ergoline had only been speculative. 10-12 In this chapter we
discuss the use of gene disruption upon the ergot alkaloid biosynthetic gene cluster of A.
fumigatus and analysis of the ergot profiles of the AeasF, AeasE, AeasC, and AeasA
knockout mutants that were conducted in collaboration with the group of Professor
Daniel Panaccione at the University of West Virginia.
Firstly, mutants of A. fumigatus disrupted at the easE and easC alleles (AeasE and
AeasC) provided evidence that the easE and easC gene products were involved in the
cyclization of ergoline ring C based on the accumulation of an early biosynthetic
intermediate in these disrupted strains (Figure 2.1). Secondly, A. fumigatus mutants
disrupted at the easA allele (AeasA), along with analysis of the accumulating biosynthetic
intermediate, indicated that easA is responsible for formation of ring D (Figure 2.1).
Augmentation of this A. fumigatus disruption mutant with the easA allele from C.
purpurea provided evidence that the easA gene product controls a proposed branch point
of ergot alkaloid biosynthesis that occurs upon formation of ergoline ring D. These
results guided efforts toward the in vitro cloning, heterologous expression, and functional
characterization of these individual genes to investigate the formation of ergoline rings C
and D.
Figure 2.1. Early ergot pathway enzymes and associated functions toward the cyclization
of ergoline ring C and D as labeled in fumigaclavine C 14.
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Experimental Methods
A. fumigatus Gene Disruption and Complementation
(Performed by C.M. Coyle and K.E. Goetz in Panaccione Lab)
A. fumigatus gene disrupted mutants were prepared by our collaborators in the
Panaccione lab using previously reported protocols.8' 1 Gene disruption constructs were
made by PCR amplification of an internal fragment of A. fumigatus genes dmaW
(fgaPTs) (XM_751048), easF (XM_751050), easC (XM_751047), easE (XM_751049),
and easA (XM_751040), from A. fumigatus genomic DNA prepared following Gene
Clean Spin Protocol (Bio 101, Vista, CA). Disruption constructs were prepared by
ligating the amplified PCR products into TA cloning vector pCR2. 1. Prior to
transformation into A. fumigatus protoplasts, disruption constructs were linearized by
restriction digest that cut once within the internal gene fragment along with a NotI
linearized hygromycin resistance plasmid pMOcosX (Orbach, 1994). A. fumigatus
protoplast transformations were performed according to previously reported protocols of
Murray et al. with modifications by Coyle et al.8 '15 Transformant selection was
conducted on regeneration medium plates containing hygromycin B (300pg/mL) as
described by Panaccione et al. 16 Transformants were screened using southern blot and by
PCR assays amplifying allele junctions resulting from homologous recombination of the
native copy of the gene with the disruption construct as previously described by Coyle et
al.8
Complementation of the gene disrupted A. fumigatus mutants was conducted by
ectopic insertion of a PCR amplified functional copy of the respective gene with flanking
regions into the mutant genome based on the protocol of Coyle et al.13 The PCR product
and a phleomycin resistance plasmid, NotI linearized pBC-phleo (Fungal Genetics Stock
Center, University of Missouri-Kansas City), were transformed into the gene disrupted
mutant. Transformants were selected on a regeneration medium (100 pg/mL)16 and PCR
assays were used to verify the presence of the original gene disruption construct along
with the introduced functional copy of the wild type gene.
Analysis of Ergot Alkaloid Profiles of A. fumigatus by and Gene Disrupted Mutants
(A. fumigatus cultures, extracts, and fluorescent HPLC analysis were performed by
C.M. Coyle and K.E. Goetz in Panaccione Lab, LC-MS analysis and preparation of
N-Me-DMAT 4 standard performed by J.Z. Cheng in O'Connor Lab)
A. fumigatus sporulating cultures were grown on potato dextrose agar (20g
dehydrated potato, 20 g glucose, 15 g agar per liter at 37 0C). Culture media was
extracted with 80% methanol. HPLC analysis of extracts were conducted via
fluorescence detection8 with a C18 column Prodigy 5 ptm ODS3, 150 mm x 4.6 mm;
(Phenomenex Torrance, CA) and a mobile phase multilinear binary gradient from 5:95 to
75:25 (acetonitrile:50 mM aqueous ammonium acetate). 17 Eluting fractions were
monitored by fluorescence detection with excitation and emission wavelengths of 272 nm
/ 372 nm or 310 nm / 410 nm. Peaks correlating to festuclavine 11 and fumigaclavines A
18, B 19, and C 14 were identified based on previous mass spectral analysis of A.
fumigatus extracts. N-Me-DMAT 3 standard was enzymatically prepared using
heterologously expressed DmaW prenyltransferase7 (see Chapter 5). Chanoclavine-I 6
standard was supplied by B.A. Tapper (AgResearch, Palmerston North, New Zealand).
Agroclavine 10 standard was purchased from Sigma (St. Louis, Missouri). Setoclavine 22
isosetoclavine 23 standards were prepared by the oxidation of agroclavine 10 with
horseradish peroxidase and H20 2 or with peroxidase-rich plant extract as previously
described.17 , 19-21
LC-MS analysis of extracts were conducted with an Acquity Ultra Performance
BEH C18 column (2.1 x 100 mm; 1.7 rn particle size) and eluted with a flow rate of 0.5
mL/min linear gradient (Acetonitrile:0.1 % formic acid water) of 20:80 to 80:20 over 5
min. Mass detection was conducted on a Micromass LCT Premier TOF MS (Waters,
Milford, MA) with an electrospray ionization source set in positive mode.
Feeding A. fumigatus easC Disrupted Mutants with Chanoclavine-I
(Performed by K.E. Goetz and C.M. Coyle in Panaccione Lab)
Cultures of A. fumigatus AeasC mutants were fed with chanoclavine-I 6 in order
to observe whether the enzyme catalyzed reaction steps downstream of chanoclavine-I 6
were still functional. An A. fumigatus AdmaW gene disrupted mutant, which is blocked at
the first pathway determinant step toward ergot alkaloid biosynthesis8 , served as a
positive control. Cultures were grown in triplicate starting with 60,000 conidia in 200 pL
of lactose-malt extract-arginine broth in culture tubes. 22
Chanoclavine-I 6 (26.7 nmol in 1 pL of methanol) was added to the culture tubes
of A. fumigatus AeasC, while 1 gL of methanol was added to the AdmaW control
cultures. All cultures were grown at room temperature for three days. Extraction of
alkaloids from the cultures were conducted by adding 800 pL of methanol and ten 3-mm
diameter glass beads with agitation using a Fast Prep FP 120 (Q-biogene, Irving, CA) at
6m per sec for 30 sec. Subsequently extracts were filtered through 0.2 pM nylon filters
and analyzed by HPLC.
Results and Discussion
A. fumigatus Gene Disruption Mutants and Analysis of Ergot Alkaloid Profiles
A. fumigatus Genes dmaW and easF
The dmaW gene product had been previously demonstrated to prenylate L-
tryptophan 1 to yield DMAT 3 (Figure 2.1). The gene disruption mutant AdmaW (A.
fumigatus) displayed loss of all ergot alkaloids production when compared to the wild
type strain as evidenced by LC-MS analysis (Table 2.1, Figure 2.2-2.3), consistent with
previous knockout studies of dmaW in A. fumigatus and N. lolii.7'8 Wild type A.
fumigatus culture extracts displayed accumulation of downstream ergot alkaloids
festuclavine 11 at m/z 241 and fumigaclavine C 14 at m/z 367 as evidenced by LC-MS
analysis, while the Adma W mutant did not show any trace of either of these compounds.
Table 2.1. A. fumigatus wild type gene disrupted mutants and the accumulation of
pathway intermediates detected by LC-MS. ( - ) Indicates accumulation of corresponding
mass in LC-MS analysis of A. fumigatus wild type and gene disrupted culture extracts.
Corresponding LC-MS chromatograms are shown in corresponding Figures 2.2-2.4, 2.6,
2.7,2.9.
DMAT N-Me- Chano-I Chano-I- Festuclavine Fumigaclavine
A.fumigatus DMAT aldehyde C
Culture
Description 3 4 6 7 11 14
[M+H]* [M+H]* [M+H]* [M+H]* [M+H]* [M+H]*
273 287 257 255 241 367
wild type -_-
A dmaW
A easF
A easE
A easC -
A easA -_-
Figure 2.2. LC-MS trace of A. fumigatus wild type culture extract (Peak intensities for
this set of chromatograms have been normalized to allow relative comparison of
compound masses present).
A. Selected ion monitoring for ergot alkaloids festuclavine 11 [M+H]+ = 241 and
fumigaclavine C 14 [M+H]* = 367. Displays masses corresponding to wild type ergot
alkaloids festuclavine 11 [M+H] = 241 and fumigaclavine C 14 [M+H]* = 367. The
broad peak at 0.75 to 0.80 min were attributed to compounds extracted from the culture
media that are not identifiable as ergot alkaloids or pathway intermediates.
B. Selected ion monitoring for intermediates DMAT 3 [M+H]* = 273, N-Me-DMAT 4
[M+H]* = 287, chanoclavine-I 6 [M+H]* = 257, chanoclavine-I-aldehyde 7 [M+H]* =
255. This trace shows absence of observable pathway intermediates in the ergot alkaloid
biosynthetic pathway.
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Figure 2.3. LC-MS trace of A. fumigatus AdmaW culture extract (Peak intensities for this
set of chromatograms have been normalized to allow relative comparison of compound
masses present).
A. Selected ion monitoring for ergot alkaloids festuclavine 11 [M+H]f= 241 and
fumigaclavine C 14 [M+H]* = 367. This trace shows absence of ergot alkaloids that are
observed in wild type A. fumigatus.
B. Selected ion monitoring for intermediates DMAT 3 [M+H]* = 273, N-Me-DMAT 4
[M+H]* = 287, chanoclavine-I 6 [M+H]* = 257, chanoclavine-I-aldehyde 7 [M+H]* =
255. This trace shows absence of observable pathway intermediates in the ergot alkaloids
biosynthetic pathway.
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The gene easF, proposed to be a S-adenosyl methionine (SAM) dependent N-
methyltransferase, was similarly disrupted in A. fumigatus. This AeasF strain displayed
accumulation of dimethylallyl tryptophan (DMAT) 3 at m/z 273 (Table 2.1 and Figure
2.4). This result supports the conclusions derived from Claviceps purpurea feeding
studies conducted by Otsuka et al. 23 These authors proposed that N-methylation does not
occur after ring C cyclization, but occurs instead on the earlier biosynthetic intermediate
DMAT 3 (Figure 2. 1).23,24 Our observation that DMAT 3 accumulates in AeasF A.
fumigatus is also consistent with recent enzymology studies using heterologously
expressed A. fumigatus easF gene product by Rigbers et al. 5 Therefore, observations
from both our in vivo gene disruption data in the AeasF mutant, coupled with in vitro
easF gene product characterization, demonstrates that EasF catalyzes the N-methylation
of DMAT 3 to yield N-Me-DMAT 4 in the second pathway step toward ergot alkaloid
biosynthesis. 25
Figure 2.4. LC-MS trace of A. fumigatus AeasF culture extract (Peak intensities for this
set of chromatograms have been normalized to allow relative comparison of compound
masses present).
A easF
/' N-methyl transferase 
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DMAT N-Me-DMAT
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A. Selected ion monitoring for ergot alkaloids festuclavine 11 [M+H]+= 241 and
fumigaclavine C [M+H]* = 367. This trace shows absence of ergot alkaloids that are
observed in wild type A. fumigatus.
B. Selected ion monitoring for intermediates DMAT 3 [M+H]* = 273, N-Me-DMAT 4
[M+H]* = 287, chanoclavine-I 6 [M+H]* = 257, chanoclavine-I-aldehyde 7 [M+H]*=
255. This trace displays the mass corresponding to DMAT 3 [M+H]*= 273 pathway
intermediate.
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A. fumigatus genes easE and easC and the formation of ergoline ring C
Following the N-methylation by EasF, a set of proposed successive oxidations
were required to form the ergoline C ring (Figure 2.1).26 The gene products of easE and
easC were potential candidates to carry out these oxidative steps as they were
homologous to FAD oxidoreductase and catalase respectively. 0 ' 12 Gene disrupted
mutants of A. fumigatus AeasE and AeasC both lose the ability to produce downstream
fumigaclavine and festuclavine 11 ergot alkaloids while the pathway intermediate N-Me-
DMAT 3 accumulates, as evidenced by HPLC and LC-MS analyses (Table 2.1, Figure
2.1).
Fumigaclavines A 18, B 19, C 14 and festuclavine 11 that were identified in the
HPLC trace of the A. fumigatus wild type culture, were not detected in the AeasE or
AeasC mutants (Figure 2.5). Instead the HPLC traces for AeasE or AeasC mutant cultures
showed the accumulation of a peak eluting at 46 min that is not present in the wild type
cultures (Figure 2.5). Subsequent LC-MS analysis of the A. fumigatus AeasE and AeasC
culture extracts displayed accumulation of a mass at m/z 287 expected for N-Me-DMAT
4 (Table 2.1, Figure 2.6-2.7). The N-Me-DMAT 4 intermediate that accumulated in both
AeasE and AeasC was further verified by co-elution with an enzymatically prepared N-
Me-DMAT 4 standard using HPLC (Figure 2.5). This evidence indicates that both gene
products of easE and easC mutants were blocked in ergoline ring C formation and instead
accumulated the N-Me-DMAT 4 pathway intermediate. These data clearly implicate the
role of easE and easC in ergoline biosynthesis. Moreover, the accumulation of N-Me-
DMAT 4 suggests that this compound is the immediate precursor to chanoclavine-I 6, as
proposed by early feeding studies.12,23,26
Gene disruption of an easE homologue in ergot alkaloid producing Claviceps
purpurea also accumulated the pathway intermediate N-Me-DMAT 4, as well as trace
amounts of DMAT 3.2 These results parallel our observations that easE and easC in A.
fumigatus were necessary for the formation of ring C in ergot alkaloid biosynthesis.
Figure 2.5. Fluorescence HPLC ergot alkaloid profiles of cultures wild type (black line),
gene disrupted easE (AeasE, blue line), and gene disrupted easC (AeasC, red line). N-
Me-DMAT 4 standard (green line). Adapted from Goetz et al.28
Wild type displays accumulation of alkaloids (B = fumigaclavine B 19, Ch =
chanoclavine-I 6, F = festuclavine 11, A = fumigaclavine A 18, and C = fumigaclavine C
14). AeasC and AeasE gene disrupted mutants display accumulation of intermediate N-
Me-DMAT 4 with loss of ergot alkaloids that are produced in the wild type. Detection
was by fluorescence with excitation at 272 nm and emission at 372 nm.
20-
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F C
wild type -
N-Me-DMAT
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B Ch
Figure 2.6. LC-MS trace of A. fumigatus AeasE culture extract (Peak intensities for this
set of chromatograms have been normalized to allow relative comparison of compound
masses present).
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A. Selected ion monitoring for ergot alkaloids festuclavine 11 [M+H]* = 241 and
fumigaclavine C 14 [M+H]* = 367. This trace shows absence of ergot alkaloids that are
observed in wild type A. fumigatus.
B. Selected ion monitoring for intermediates DMAT 3 [M+H]* = 273, N-Me-DMAT 4
[M+H]* = 287, chanoclavine-I 6 [M+H]* = 257, chanoclavine-I-aldehyde 7 [M+H]*=
255. This trace displays the mass corresponding to N-Me-DMAT 4 [M+H]* = 287
pathway intermediate.
A.
100, m/z 241+367
m/z 287 m/z 273+287+257+255
Figure 2.7. LC-MS trace of A. fumigatus AeasC culture extract (Peak intensities for this
set of chromatograms have been normalized to allow relative comparison of compound
masses present).
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A. Selected ion monitoring for ergot alkaloids festuclavine 11 [M+H]+ = 241 and
fumigaclavine C 14 [M+H]* = 367. Shows absence of ergot alkaloids that are observed in
wild type A. fumigatus.
B. Selected ion monitoring for intermediates DMAT 3 [M+H]* = 273, N-Me-DMAT 4
[M+H]* = 287, chanoclavine-I 6 [M+H]* = 257, chanoclavine-I-aldehyde 7 [M+H] =
255. Displays mass corresponding N-Me-DMAT 4 [M+H]* = 287 pathway intermediate.
The peaks at 0.9 min and 5.5 min were attributed to compounds extracted from the
culture media that are not identifiable as ergot alkaloids or pathway intermediates.
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While the easE gene product, homologous to FAD dependent oxidoreductases,
could catalyze the 4 electron oxidation necessary for ring C cyclization, the role of the
easC gene product catalase and its direct involvement in the oxidative transformation to
form ring C is not well understood. 0', 12,26,29, 30 The easC catalase may serve in a general
protective role to A. fumigatus, a function that is observed for many other catalases in
previous studies.4, 3 1, 32 To further investigate whether the easC catalase gene may be
necessary for any catalytic steps after ring C cyclization to form chanoclavine-I 6, an
exogenous supply of chanoclavine-I 6 was fed to the AeasC mutant to determine if
downstream ergot alkaloid production would be restored. To compare levels of
downstream ergot alkaloid production, chanoclavine-I 6 was also fed to a AdmaW mutant
culture as a positive control.
If the functional role of easC was limited only to ring C cyclization, it would be
expected that exogenously fed chanoclavine-I 6 would be converted by the downstream
pathway enzymes to give festuclavine 11 and fumigaclavine A 18, B 19, and C 14 in
similar levels to the AdmaW mutant fed with chanoclavine-I 6. In contrast, if easC were
acting in a general protective role involved in later steps of the pathway after ring C
cyclization, it would be expected that the AeasC strain fed with chanoclavine-I 6 would
show poor or altered levels of downstream ergot alkaloid production relative to the
Adma W fed with chanoclavine-I 6. Interestingly, downstream ergot alkaloid production
was restored in both AeasC and AdmaW cultures to similar levels when fed exogenously
supplied chanoclavine-I 6 (Table 2.2). These observations suggested that the easC gene
product was directly involved in the pathway step toward for the cyclization of ergoline
ring C, thus not necessarily functioning as a general protective catalase in other pathway
steps toward ergot alkaloid biosynthesis. These findings also further demonstrate that
both EasC and EasE need to be present to catalyze the cyclization of ring C to form
chanoclavine-I 6 from N-Me-DMAT 4. Efforts to heterologoulsy express and
characterize the functions of easC and easE gene products in vitro were described in
Chapter 5.
Table 2.2. Conversion of exogenous chanoclavine-I 6 (26.7 nmol) into downstream ergot
alkaloids by cultures of Aspergillusfumigatus. Adapted from Goetz et al.28
Ergot Alkaloids (nmol; mean i standard error)
Culture Chano-I Festuclavine Fumiga Fumiga Fumiga
B A C
6 14 19 18 14
AeasC control <DL <DL <DL <DL <DL
(no Chano-I)
AdmaW control <DL <DL <DL <DL <DL
AeasC+ 16.0+2.7 0.6±0.08 0.7+0.03 1.4+0.03 0.03±0.01
Chano-I
AdmaW+ 19.4+1.1 0.3±0.01 0.6+0.04 1.4±0.09 0.04+0.01
Chano-I
medium +
Chano-I 26.1±3.7 <DL <DL <DL <DL
(uninoculated)
Fumiga (Fumigaclavine)
Chano-I (chanoclavine-I)
<DL, below detection limit
A. fumigatus gene easA and the formation of ergoline ring D
The easA gene, homologous to the Old Yellow Enzyme (OYE) class of flavin
dependent oxidoreductases, served as another target for gene disruption experiments.
OYE from Saccharomyces carlsbergensis had been extensively studied by Massey and
co-workers.33' 34 OYE enzymes display activity toward the reduction of carbon-carbon
double bonds of a,p-unsaturated ketones and aldehydes. 34 , 35 In the early ergot alkaloid
biosynthetic pathway, the only proposed intermediate containing an a,p-unsaturated
aldehyde was chanoclavine-I-aldehyde 7; thus the easA gene product was likely to play a
role in this pathway step to reduce this carbon-carbon double bond to catalyze ring D
formation.
When analyzed by fluorescence HPLC (Figure 2.8), the AeasA A. fumigatus
mutant displayed loss of festuclavine 11 and fumigaclavines A 18, B 19, and C 14, but
instead accumulated novel peaks at 32 min and 37 min, which were identified as
chanoclavine-I 6 and chanoclavine-I-aldehyde 7, respectively. The peak at 32 min was
identified by co-elution with chanoclavine-I 6 standard by HPLC (Figure 2.8) and
corresponded to a mass of m/z 257 by LC-MS which is consistent with the mass of
chanoclavine-I 6. Alternatively, the peak at 37 min corresponded to a mass of m/z 255 by
LC-MS which is the expected mass of chanoclavine-I-aldehyde 7 (Table 2.1, Figure 2.9).
Further analysis by 'H-NMR resulted in a spectra that matched that previously reported
for chanoclavine-I-aldehyde 7 (Figure 3.12).36
These data suggested that the easA gene product catalyzed the formation of the
ergoline ring D, where the AeasA mutant accumulated upstream precursors chanoclavine-
I 6 and chanoclavine-I-aldehyde 7. In Chapter 3, the heterologous expression and
finctional characterization of the A. fumigatus easA gene product is presented,
demonstrating that EasA catalyzes the reduction of chanoclavine-I-aldehyde 7 to cyclize
ergoline ring D in vitro.
Figure 2.8. Fluorescence HPLC ergot alkaloid profiles of cultures wild type, gene
disrupted easA (AeasA), and gene disrupted easA complemented with C. purpurea easA
(AeasA + C.p. easA). Adapted from Coyle et al.13
Wild type displays accumulation of alkaloids (B = fumigaclavine B 19, F = festuclavine
11, A = fumigaclavine A 18, C = fumigaclavine C 14). AeasA gene disrupted mutant
displays accumulation of intermediates (Ch = chanoclavine-I 6 and Ald = chanoclavine-I-
aldehyde 7). AeasA + C.p easA gene disrupted mutant complemented with C. purpurea
easA accumulated alkaloids (Ag = agroclavine 10, and S/I = setoclavine 22 or
isosetoclavine 23). The relative sequence of elution for the setoclavine 22 and
isosetoclavine 23 diastereoisomeric pair remains to be determined. Detection was by
fluorescence with excitation and emission (272 nm / 372 nm) and (310 nm / 410 nm).
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Figure 2.9. LC-MS trace of A. fumigatus AeasA culture extract (Peak intensities for this
set of chromatograms have been normalized to allow relative comparison of compound
masses present).
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A. Selected ion monitoring for ergot alkaloids festuclavine 11 [M+H]+ = 241 and
fumigaclavine C 14 [M+H]* = 367. This trace shows absence of ergot alkaloids that are
observed in wild type A. fumigatus.
B. Selected ion monitoring for intermediates DMAT 3 [M+H]* = 273, N-Me-DMAT 4
[M+H]* = 287, chanoclavine-I 6 [M+H]* = 257, chanoclavine-I-aldehyde 7 [M+H]*=
255. Displays masses corresponding to chanoclavine-I 6 [M+H]* = 257 and
chanoclavine-I-aldehyde 7 [M+H]*= 255 pathway intermediates.
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Augmentation of A.fumigatus AeasA with C. purpurea easA and resulting ergot
alkaloid structural divergence
The accumulation of chanoclavine-I-aldehyde 7 in AeasA suggested that the easA
gene product plays a catalytic role in the cyclization of ergoline ring D. As presented in
Chapter 1, ergot alkaloids with a fully saturated D ring of the ergoline structure such as
festuclavine 11 were produced by A. fumigatus while ergot alkaloids that have an
unsaturated ergoline D ring between the C8 and C9 positions such as agroclavine 10 were
produced by Clavicipitaceous fungi C. purpurea and N. lolii. Due to the shared early
steps of ergot alkaloid biosynthesis observed across various fungal species, chanoclavine-
I-aldehyde 7 was likely to be the last common precursor prior to pathway divergence at
ring D formation, to give either agroclavine 10 or festuclavine 11 derived downstream
ergot alkaloids. Therefore, the easA gene product was likely to function at the branch
point of ergot alkaloid biosynthesis.
To test whether the easA gene product functioned at this structural branch point in
ergot alkaloid biosynthesis, the A. fumigatus AeasA mutant was augmented with a wild
type allele of easA from a C. purpurea fungal species that produces agroclavine 10.
HPLC analysis of the A. fumigatus AeasA + C. purpurea easA (CpeasA) augmented
mutant showed significantly reduced accumulation of peaks identified with chanoclavine-
I 6 and chanoclavine-I-aldehyde 7 that were observed in the AeasA gene disrupted
profile. Peaks that were associated with festuclavine 11 and fumigaclavines produced by
wild type A. fumigatus were also not present in the augmented CpeasA mutant (Figure
2.8). Notably, three novel peaks appeared in the HPLC fluorescence profile for the
augmented CpeasA mutant, which included peaks eluting at 39 min, 42 min, and 44 min
(Figure 2.8). The peak at 44 min was identified by co-elution with an agroclavine 10
standard on HPLC, and subsequent analysis by LC-MS revealed a compound with m/z
239, which is consistent with the expected mass of agroclavine 10 (Figure 2.1 OA). Peaks
at 39 min and 42 min were similarly identified by co-elution with standards for the
diastereoisomeric pair setoclavine 22 and isosetoclavine 23 on HPLC (Figure 2.8), where
further analysis by LC-MS demonstrated that these peaks corresponded to a mass of m/z
255, which is the expected mass of setoclavine 22 and isosetoclavine 23 (Figure 2.10. B,
C).
Figure 2.10. LC-MS analysis of peaks collected from HPLC of A. fumigatus AeasA + C.
purpurea easA (Figure 2.8) at 39, 42, and 44 min.
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A. LC-MS analysis of peak collected at 44 min from HPLC. Selected ion monitoring for
m/z 239 displays peak at 1.4 min which corresponds to the expected mass of agroclavine
10 at [M+H]* = 239.
B. LC-MS analysis of peak collected at 42 min from HPLC. Selected ion monitoring for
m/z 255 displays peak at 0.8 min which corresponds to the expected mass of setoclavine
22 / isosetoclavine 23 at [M+H]* = 255. Peak at 5.5 min was a trace impurity not
identifiable as an ergot alkaloid or pathway intermediate.
C. LC-MS analysis of peak collected at 39 min from HPLC. Selected ion monitoring for
m/z 255 displays peak at 0.8 min which corresponds to the expected mass of setoclavine
22 / isosetoclavine 23 at [M+H]* = 255. Peak at 5.5 min was a trace impurity not
identifiable as an ergot alkaloid or pathway intermediate.
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These results demonstrated that the A. fumigatus AeasA augmented with C. purpurea
easA allele resulted in a drastically different ergot alkaloid profile where wild type A.
fumigatus ergot alkaloids festuclavine 11 and fumigaclavine production was not restored.
Instead, the production of agroclavine 10 and its oxidation products setoclavine 22 and
isosetoclavine 23, normally produced by C. purpurea, was observed. Setoclavine 22 and
isosetoclavine 23 were oxidation products derived from agroclavine 10, and have been
previously observed when agroclavine 10 is fed to cultures of A. fumigatus,37 so the
production of these diasteroisomeric products 22 and 23 provides additional evidence that
agroclavine 10 is produced in this A. fumigatus strain. The considerable change in ergot
profile that is dependent on the individual easA gene demonstrates that the easA gene
product controls the branch point of ergot alkaloid biosynthesis toward the production of
either agroclavine 10 or festuclavine 11 derived downstream products. In our efforts to
understand the mechanism governing pathway divergence in ergot alkaloids, these
findings guided the heterologous expression and functional characterization of the easA
homologue from the agroclavine 10 producer N. lolii described in Chapter 4.
Conclusion
This chapter describes the assignment of function to clustered ergot alkaloid
biosynthetic genes. Gene disruption of dwaW led to the loss of ergot alkaloid production
in A. fumigatus, reinforcing the role of dma W in the first committed step of ergot alkaloid
biosynthesis. Disruption of easF and the resulting accumulation of DMAT 3, established
the role of this gene as an N-methyltransferase at the second step of ergot biosynthesis.
The resulting ergot profiles of both of these gene disrupted mutants parallel the results
from in vitro functional characterization studies that have been reported for dwaW and
easF gene products.3' 2 5
Knockout mutants of easE and easC, AeasE and AeasC, show accumulation of
common pathway intermediate N-Me-DMAT 4, demonstrating their catalytic role in the
formation of ergoline ring C. The chanoclavine-I 6 feeding studies to AeasC further
demonstrated that the easC gene product was essential for the formation of ergoline ring
C and that this gene product did not play a role as a general protective catalase in other
parts of the ergot pathway for A. fumigatus. Efforts to understand the mechanism in
which EasE and EasC work to form ergoline ring C were investigated via the
heterologous expression and functional characterization of these proteins as detailed in
Chapter 5.
Gene disruption of A. fumigatus easA, and the resulting accumulation of
chanoclavine-I 6 and chanoclavine-I-aldehyde 7 with loss of downstream ergot alkaloids,
established the functional role of EasA in the cyclization of ergoline ring D.
Augmentation of A. fumigatus AeasA mutant with the C. purpurea easA allele resulted in
production of agroclavine 10 and its oxidation products as opposed to festuclavine 11 or
fumigaclavines of wild type A. fumigatus. This suggests that subtle catalytic active site
differences across easA homologues from different fungal species may be responsible for
structural divergence of alkaloids across different ergot classes. The mechanistic
principle governing such pathway divergence caused by the easA gene product is
discussed in greater detail in Chapters 3 and 4.
These in vivo gene disruption experiments described in this chapter were essential
toward guiding our efforts toward the in vitro cloning, heterologous expression, and
functional characterization of the enzymes responsible for ergoline ring C and D
formation.
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Chapter 3 . Role of Redox Enzymes Involved with the
formation of Ergoline Ring D
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Introduction
The easA gene is conserved in ergot alkaloid biosynthetic clusters across
divergent fungi including A. fumigatus, C. purpurea, and N. lolii, and is believed to
participate in the early pathway formation of the ergoline ring.' The gene knockout
mutant AeasA of A. fumigatus, in contrast to the wild type strain, failed to accumulate
downstream ergot alkaloids fumigaclavine C 14 but instead displayed accumulation of
upstream intermediates chanoclavine-I 6 and chanoclavine-I-aldehyde 7 as discussed in
Chapter 2. This finding demonstrated that the easA gene product played a catalytic role in
the cyclization of ergoline ring D.
The gene product of A. fumigatus easA (EasAAf) was proposed to be a suitable
candidate enzyme for turning over the chanoclavine-I-aldehyde 7 substrate, as it displays
protein sequence homology to the Old Yellow Enzyme (OYE) family of proteins (Figure
3.1).2-5 OYE was initially isolated from brewer's bottom yeast and first described by
Warburg and Christian in 1932.6 In the years following, Theorell purified OYE and
demonstrated that OYE consisted of a colorless apoprotein and a yellow co-factor
identified as flavin-mononucleotide (FMN).7
In later work, Vincent Massey's group extensively characterized an OYE from S.
carlsbergensis brewer's bottom yeast (designated as OYE 1)8. In general, substrates for
members of the OYE family included oxygen, quinones, and a,p-unsaturated double
bonds of aldehydes and ketones (Figure 3.2).2, 4,8-13 While the exact physiological
function of OYE 1 has only been speculative, other homologues of OYE have been
associated with metabolic pathways in bacteria and plants (Figure 3.2).14-17
Figure 3.1. Protein sequence alignments with EasAAf and Old Yellow Enzyme
homologues. Conserved amino acid residues important to the OYE mechanism are
highlighted in red.
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Defining characteristics of OYE include a non-covalently bound FMN as a
cofactor and the requirement of NADPH as a reducing agent. The reduction of the
carbon-carbon double bonds of a4-unsaturated aldehydes or ketones by OYE involves
two half reactions (Figure 3.3). First, in the reductive half reaction for OYE, one
molecule of NADPH binds to the OYE active site, where a hydride is transferred from
NADPH to reduce the FMN cofactor of OYE. Subsequently, NADP+ leaves the active
site. 4, In the oxidative half reaction, the hydride on the reduced FMN cofactor of OYE
reduces a substrate such as 2-cyclohexenone to yield cyclohexanone. 12, 19 The catalytic
cycle of OYE has been previously demonstrated to function in a ping-pong bi-bi
mechanism. 2,10, 11, 19-21
Figure 3.2. Representative substrates of various OYE homologues. A. 2-cyclohexenone
to 2-cyclohexanone (Saccharomyces carlsbergensis) 2; B. Acrolein to Propionaldehyde
(Saccharomyces carlsberensis, Saccharomyces cerevisiae)9 ' 17 C. Morphinone to
Hydromorphone (Pseudomonas putida)'6' 22; D. 9S,13S-12-oxophytodienoate to 1S,2S-3-
oxo- 2(2'[Z]-pentenyl)-cyclopentane-1-octanoate (Lycopersicon esculentum, Arabidopsis
thaliana)1 5 ; E. Chanoclavine-I-aldehyde 7 to Dihydrochanoclavine-I-aldehyde 24
(Aspergillusfumigatus)23,24
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Figure 3.3. Illustrated catalytic cycle for OYE with NADPH and 2-cyclohexenone
substrate (Ox = oxidative half reaction, Red = reductive half reaction, E:FMNH2 OYE
with reduced FMN co-factor, E:FMN = OYE with oxidized FMN co-factor).
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Previous mechanistic studies by the Massey group and the elucidation of the
OYEi crystal structure by Fox et al., have identified catalytic residues that were
important in the reduction of a,p-unsaturated ketones and aldehydes.2, 4, 9-11, 25 In protein
sequence alignments, A. fumigatus EasA (EasAAf) shares identical residues to OYE1
that were involved in the binding and oxidation of NADPH and reduction of a,p-
unsaturated ketone or aldehyde substrates (Figure 3.1). The catalytic residues in the
active site of OYE1 have been identified as T37, Q 114, H191, N194, and Y196, which
correspond to T31, Q106, H173, N176, and Y178 in the EasAAf protein sequence
2,4,10,11(Figures 3.1, 3.4-3.6). 4 1 1 Based on the crystal structure of OYE1 with an NADPH
analogue, H191 and N 194 of OYE were believed to be hydrogen bond donors that
interact with the amide oxygen of NADPH (Figure 3.4), thus positioning the C4 of the
nicotinamide moiety adjacent with the N5 of flavin.2,3,19 It has also been suggested that
H191 and N194 play a role in reducing a,p-unsaturated aldehyde substrates by hydrogen
bonding to the carbonyl oxygen, thus stabilizing the transition state after a hydride is
transferred to the P carbon double bond. Y196 acts as a general acid for the substrate
either concurrently with or after hydride transfer from FMN.4 Q114 of OYE1 has been
shown to facilitate hydrogen bond interactions with the 02 and N3 of the FMN
structure.10 The hydroxyl group of T37 forms a hydrogen bond with the 04 of FMN
(Figure 3.4)."
Figure 3.4. Catalytic active site residues of OYE 1 and the proposed mechanism for the
reduction of 2-cyclohexenone to yield cyclohexanone.2-4, 0,"1 , 19
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4Figure 3.5. A. H173 and N176 hydrogen bonding interactions with the amide
nicotinamide moiety of NADPH. B. Conserved active site residues of A. fumigatus EasA
homologue and proposed mechanism for the reduction of chanoclavine-I-aldehyde 7 to
yield a cyclic iminium intermediate 9. EasG serves as the NADPH dependent reductase
in the final step to yield festuclavine 11.
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Figure 3.6. Homology model of EasAAf with chanoclavine-I-aldehyde 7 in active site,
estimated distances are in angstroms. Residues H 173 and N 176 are believed to be
hydrogen bond donors to the carbonyl oxygen while the Y 178 residue acts as a proton
donor to the C8 position of chanoclavine-I-aldehyde 7. The reduced flavin N5 position
transfers a hydride to the C9 position of the substrate.
The homology model of EasAAf and estimated docking distance of chanoclavine-I-
aldehyde 7 in the active site were obtained using programs SWISS-MODEL Workspace
26,27 and DockingServer . Modeling and estimated docking distances utilized the
structure of S. carlsbergensis OYE (PDB: 1 OYC) as a template, which shares 40%
identity and 58% similarity in protein sequence to EasA_Af.
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Based on the protein sequence homology of EasAAf to the OYE like family of
enzymes, it was hypothesized that EasAAf could reduce the a,p-unsaturated aldehyde
substrate chanoclavine-I-aldehyde 7 in the ergot alkaloid biosynthetic pathway to form a
proposed cyclic iminium intermediate 9 (Figure 3.5B). It was further proposed that the
resultant cyclic iminium intermediate 9 of EasAAf would require a downstream
reductase to form festuclavine 11 (Figure 3.5B).
While comparing conserved genes across ergot alkaloid biosynthetic clusters of
different fungi, our attention focused on a putative NADPH-dependent oxidoreductase
EasG. This candidate enzyme consisted of a domain homologous to the Rossmann fold
NAD(P)H/NAD(P)* binding domains found in dehydrogenases. 29-32 Therefore, it seemed
likely that EasG could facilitate the reduction of the proposed cyclic iminium
intermediate 9 to yield festuclavine 11.
This chapter describes the functional characterization of EasAAf, an OYE
homologue, and EasG, an NADPH dependent reductase, that catalyze the critical
cyclization of ring D in ergot alkaloid biosynthesis. Gene products of easA and easG
enzymes from A. fumigatus were cloned and heterologously expressed in E. coli and
shown to catalyze the formation of festuclavine 11 from substrate precursor
chanoclavine-I-aldehyde 7.
Experimental Methods
General materials and methods
Recombinant DNA cloning procedures were performed using pGEM-T vector
(Promega) propagated in E. coli Top 10 (Invitrogen). Protein expression was conducted in
E. coli BL-21(DE3) (Invitrogen). PCR amplification utilized Platinum Taq DNA
Polymerase (Invitrogen). Recombinant DNA plasmids were prepared using Qiaprep Spin
Miniprep and Qiaquick Gel Extraction kits (Qiagen). Restriction enzymes and T4 DNA
ligase were purchased from New England Biolabs. Primers for cloning were synthesized
by Integrated DNA Technologies and DNA sequencing was conducted by the MIT
Biopolymers Laboratory (Cambridge, MA).
LC-MS analysis was conducted using an Acquity Ultra Performance BEH C 18
column with a 1.7 mm particle size, 2.1 x 100 mm dimension, with an acetonitrile/0. 1%
trifluoroacetic acid in water mobile phase. The column elution was coupled to MS
analysis carried out using a Micromass LCT Premier TOF Mass Spectrometer with an
ESI source (Waters).
Exact mass data were acquired on a Bruker Daltonics APEXIV 4.7 Tesla Fourier
Transform Ion Cyclotron Resonance Mass Spectrometer (FT-ICR-MS). 'H-NMR was
taken using a 500MHz Varian Inova NMR Spectrometer. A Varian Cary 50 Bio Scanning
Spectrometer was used to acquire UV-Vis spectra.
HPLC analysis was conducted on a Beckman Coulter System Gold 125 HPLC
with a model 168 photodiode array detector using a Hibar RT 250-4LiChrosorb C 18
column (Merck). Preparative HPLC was performed with a Grace Vydac C18 column.
Preparation of cDNA from Total RNA Extraction of A.fumigatus Mycelia
To clone the desired genes from A. fumigatus, total RNA was first extracted from
mycelia tissue using the Trizol RNA extraction procedure (Invitrogen). The purity of the
extracted total RNA was checked by spectrophotometer giving an absorbance A260/A2 80
of 2.1, which indicated sufficient RNA quality for the subsequent steps.33 Using the
Creator SMART MMLV reverse transcriptase (Clontech) cDNA was constructed from
the extracted total RNA from A. fumigatus using PCR.
Cloning, overexpression, and purification of EasAAf
The A. fumigatus easA gene was PCR amplified using A. fumigatus cDNA.
Primers were designed based on the nucleotide sequence of easA from the NCBI database
(XM_751040). A pair of oligonucleotide primers were used to amplify the easA gene
from cDNA: forward primer 5'-TTAGATCTGGCGAATTCGGCCATATGCGAGAAG
AACCGTCCTCTGCTCAGC-3' (with NdeI restriction site in bold) and reverse primer
5'-GACTCGAGTTAAAGCTTGCCGCTAGCGACGGGGAAATTATGCAATGC
CATA-3' (XhoI restriction site in bold). (Additional restriction sites were incorporated
into the primers to allow for cloning of easA as either an N-His 6 or C-His 6 construct.) The
PCR amplified easA gene was inserted into pGEM-T vector (Promega) for propagation
and sequencing. Subsequently, the easA sequence was excised from pGEM-T by
restriction digest and ligated into the NdeI/XhoI site of pET-28a(+) (Novagen) expression
vector as an N-His 6 construct.
Expression was carried out in LB media with Kanamycin (50 pg/mL). E. coli BL-
21 (DE3) cells were grown to an OD 60 0 of 0.7 prior to induction with IPTG (5 ptM) and
grown for 60 hours at 15 0C prior to harvesting. Cells were resuspended in buffer (20 mM
Tris-HCl, 300 mM NaCL, 10% (v/v) glycerol, pH = 8.0) and incubated on ice for 30 min
with added lysozyme (1 mg/mL) and DNAseI (10 pg/mL) and lysed by sonication.
Cellular debris was pelleted by centrifugation (15,000 x g for 1 hour).
EasAAf enzyme was purified by Ni-NTA agarose (Qiagen). The yield of active
(holo) EasAAf was estimated to be 2.5 mg per liter of culture as measured by UV
absorbance of flavin at 446 nm. Fractions containing pure EasAAf, as demonstrated by
SDS-PAGE, were collected and exchanged with dialysis buffer (50 mM K2HPO 4, 100
mM NaCl, 10% (v/v) glycerol, pH = 7.0) (Figure 3.7). Total purified EasAAf from each
expression (holo plus apoenzyme) was determined by Bradford Assay. Holoenzyme
concentration was determined using flavin absorption, where the final stock
concentration was 30 pM.
Figure 3.7. SDS-PAGE of A. fumigatus EasA (EasAAf) (42 kDa).
* 1 2 3 4 5
64 kDa
37 kDa
26 kDa
*. Invitrogen BenchMark Pre-Stained Protein Ladder.
1. buffer wash with 10 mM imidazole
2. 25 mM imidazole
3. 50 mM imidazole
4. 100 mM imidazole
5. 150 mM imidazole elution
Characterization of the bound EasAAf flavin
The bound FMN was readily released from EasAAf by denaturation of the
enzyme solution with 0.2% sodium dodecyl sulfate (SDS). 34 Precipitated protein was
removed by centrifugation at 17,000 x g, and a UV-visible spectra from 250 nm to 550
nm was taken of the free flavin in solution and compared to the spectra of FMN standard
(Figure 3.8). The released flavin from EasAAf exhibits the same absorbance maxima at
373 nm and 446 nm as the FMN standard.
The identity of the released flavin was further verified by co-migration with FMN
standard by HPLC (Figure 3.9). The samples were chromatographed using a Hibar 250-4
LiChrosorb RP-Select B 5pm column (Merck) with an acetonitrile/0.1% trifluoroacetic
acid in water mobile phase (12:88 to 95:5 from 0-15 min, 95:5 to 12:88 from 15-23 min,
at a constant flow rate of 1 mL/min) with the UV detection range set at 280 nm.
Figure 3.8. Characteristic flavin absorbance spectrum (300 nm to 550 nm).
A. Native EasA Af
B. Supernatant from EasAAf denatured with 0.2% SDS
C. FMN Standard
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Figure 3.9. Released flavin from EasAAf identified as FMN by HPLC.
HPLC chromatogram (280 nm) of supernatant from denatured EasAAf with FMN
standard. FMN elutes at 5.95 min (top). UV-Vis spectrum of peak maxima at 5.95 min
characteristic of FMN (bottom).
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Isolation and HPLC purification of chanoclavine-I-aldehyde 7
Chanoclavine-I-aldehyde 7 was purified from crude extracts of 14 day old surface
cultures of A. fumigatus easA knockout strain. This easA disrupted strain accumulated
higher amounts of chanoclavine-I-aldehyde 7 than the wild type A. fumigatus strain as
presented in Chapter 2. The Panaccione lab prepared and extracted cultures with a 4:1
mixture of methanol:water according to their previously published methods.3 5
Chanoclavine-I-aldehyde 7 was identified in the crude extracts by LC-MS analysis
(gradient of acetonitrile/0.1% trifluoroacetic acid in water mobile phase, 10:90 to 90:10
from 0-9 min, 90:10 to 10:90 from 9-10 min, at a constant flow rate of 0.5 mL/min). A
preparative HPLC method, based on the polarity of chanoclavine-I-aldehyde 7 exhibited
on the LC-MS gradient, was optimized to isolate this compound.
Chanoclavine-I-aldehyde 7 was isolated on a Grace Vydac preparative C18 column
with an isocratic elution (15:85 acetonitirile/0. 1% trifluoroacetic acid in water, constant
flow rate at 4.0 mL/min, 228 nm detection). Under these conditions, pure chanoclavine-I-
aldehyde 7 eluted at 25-26 min (Figure 3.10). Subsequent LC-MS analysis of the
preparative HPLC purified compound demonstrated that chanoclavine-I-aldehyde 7 was
not contaminated with any other compounds from the extract (Figure 3.11 and 3.12).
Figure 3.10. Isolation and purification of chanoclavine-I-aldehyde 7 EasA Af substrate.
Preparative HPLC chromatogram of crude A. fumigatus organic extract. Chanoclavine-I-
aldehyde 7 elutes at 25 minutes (225 nm detection) (top). UV-Vis spectrum of
chanoclavine-I-aldehyde 7 (17 gM) in methanol (bottom).
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Figure 3.11. Total ion counts of LC-MS chromatograms of crude A. fumigatus extract
(top) and purified chanoclavine-I-aldehyde 7 (bottom).
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Figure 3.12. LC-MS chromatograms with selected ion monitoring of chanoclavine-I-
aldehyde 7 substrate. Peak intensities for this set of chromatograms have been normalized
to allow relative comparison of compound masses present.
Selected ion monitoring of substrate chanoclavine-I-aldehyde 7 for m/z 255, m/z 239, and
m/z 241, demonstrates that there are no contaminants with masses [M]* = 239 and
[M+H]* = 241 in the purified chanoclavine-I-aldehyde 7 substrate [M+H]* = 255.
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Purified chanoclavine-I-aldehyde 7 was analyzed by 'H-NMR (500MHz Varian Inova).
The spectra matched the IH-NMR data previously reported by Floss and co-workers
(Figure 3.13).36
Purified Chanoclavine-I-aldehyde 7 (Figure 3.13):
'H-NMR (500 MHz, CD 30D) 2.03 (s, 3H), 2.77 (s, 3H), 3.45-3.49 (m, 2H), 3.84 (d, J=
4.5Hz, 1H), 4.58 (dd, J= 4.5, 10Hz, 1H) , 6.52 (d, J= 10Hz, 1H), 6.87 (d, J= 7.0Hz,
1H), 7.16 (d, J= 8.0Hz, 1H), 7.19 (d, J= 8.5Hz ,1H), 7.34 (d, J= 8.0 Hz, 1H), 9.40 (s,
1H).
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Catalytic hydrogenation of agroclavine 10 to yield festuclavine 11
Festuclavine 11 was prepared from agroclavine 10 following a previously
published protocol. The identity of the starting material agroclavine 10 was verified using
LC-MS and 'H-NMR (Figure 3.14 and 3.16). Agroclavine 10 (1 mg, 4.2 Imol) in 2 mL
of methanol was placed over 1 mg of Pt-black at 1 atm of hydrogen at 25 OC. 37 , 3 After 2
hours, the catalyst was filtered and the filtrate was evaporated under vacuum. The
resulting festuclavine 11 product was verified by LC-MS and 'H-NMR. (Figure 3.15 and
3.17).
Figure 3.14. LC-MS chromatograms with selected ion monitoring of agroclavine
standard 10. Peak intensities for this set of chromatograms have been normalized to allow
relative comparison of compound masses present.
Selected ion monitoring at m/z 239 shows that only the agroclavine standard 10 with
mass of [M+H]* = 239 is present. Mass monitoring at m/z 241 shows that there are no
contaminants with this mass in the standard. Agroclavine 10 was also incubated with
NaCNBH 3 and as expected does not react with this reducing agent.
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Figure 3.15. LC-MS chromatograms with selected ion monitoring of festuclavine
standard 11. Peak intensities for this set of chromatograms have been normalized to allow
relative comparison of compound masses present.
Selected ion monitoring at m/z 241 shows that only the festuclavine 11 mass [M+H]*=
241 is present. Selected ion monitoring at m/z 255 and m/z 239 shows that there are no
contaminants with these masses in the festuclavine standard 11.
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'H-NMR analysis of the hydrogenated product indicated the presence of only one major
diastereomer (Figure 3.17). Previous reports have demonstrated that festuclavine 11 is the
major diastereomer resulting from hydrogenation of agroclavine 10 under these
conditions. 37
Agroclavine 10 starting material (Sigma) (Figure 3.16):
IH-NMR (500 MHz, CD 30D) 1.80 (s, 3H), 2.49 (s, 3H), 2.73 (t, J=13.7Hz, lH), 2.98 (d,
J=16.3Hz, 1H), 3.26 (d, J=16.2Hz, lH), 3.36 (dd, J=4.10, 14.2Hz, 2H), 3.68 (d,
J=8.5OHz, 1H), 6.23 (s, IH), 6.89-6.92(m, 2H), 7.05 (t, J=7.1OHz, lH), 7.13 (d, 1.6Hz,
1H)
Festuclavine 11 product (Figure 3.17):
'H-NMR (500 MHz, CD 30D) 1.17 (d, J=6.5Hz, 3H), 1.38 (m, lH), 2.21 (m, lH), 2.83-
2.95 (m, 3H), 3.09 (s, 3H), 3.27 (m, 2H), 3.60 (dd, J=2.0, 12.5Hz, 1H), 3.70 (dd, J=3.5,
14.5Hz, 1H), 6.94 (d, J=7.OHz, 1H), 7.04 (d, J=1.5Hz, 1H), 7.12 (t, J=7.OHz, 1H), 7.21
(d, J=8.OHz, 1H)
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End Point Assay of EasAAf for the conversion of chanoclavine-I-aldehyde 7 to
cyclic iminium intermediate 9
To test for substrate turnover, purified EasAAf (1.5 piM) was incubated with
chanoclavine-I-aldehyde 7 (1 mM) and NADPH (1.5 mM) in 100 mM K2HPO 4 (pH =
7.0)2 buffer at 25 0C for 1 hour. The product identity was confirmed by LC-MS analysis
(gradient of acetonitrile/0. 1% trifluoroacetic acid in water mobile phase, 10:90 to 90:10
from 0-9 min, 90:10 to 10:90 from 9-10 min, at a constant flow rate of 0.5 mL/min) and
high resolution mass spectrometry.
Steady state kinetic analysis of EasAAf
The kcat and Km values for chanoclavine-I-aldehyde 7 and NADPH were obtained by
LC-MS, monitoring the initial rate of chanoclavine-I-aldehyde 7 consumption over time.
Mass spectrometry using electrospray ionization has been previously used as an assay
method for kinetic characterization of a variety of enzymes. 39 ,40 Chanoclavine-I-aldehyde
7 was quantified with a standard curve of chanoclavine-I-aldehyde 7 plotted against peak
response area for mass [M+H]* 255 (Figure 3.18). Aliquots of the reaction were
quenched in 0.1% formic acid (containing 500 nM yohimbine as an internal standard)
over a 3 min time course at 30 sec intervals. Reactions contained varying substrate ranges
of chanoclavine-I-aldehyde 7 (0.5-10 pM) and NADPH (10-500 pIM) and EasAAf at
(2.5 nM), and were incubated in 100 mM K2HPO 4 at pH = 7.0 buffer in 50 ptL volumes at
25'C under aerobic conditions.
Enzyme concentration was calculated using flavin absorption, ensuring that only
holoenzyme was considered in the protein concentration measurement. Linear regression
analysis was used to determine the initial rate of each assay. Experiments were repeated
in triplicate and data were fit using software SigmaPlot 9.0. A control to check for the
stability of chanoclavine-I-aldehyde 7 under assay conditions was conducted by setting
up a reaction containing boiled (inactive) EasAAf (2.5 nM), chanoclavine-I-aldehyde 7
(5 pM), and NADPH (500 pM). Aliquots of the reaction were quenched in 0.1% formic
acid (plus yohimbine internal standard) over time and analyzed by LC-MS. The
concentration of chanoclavine-I-aldehyde 7 was maintained over a 60 min time course,
suggesting that the disappearance of chanoclavine-I-aldehyde 7 in the EasAAf assay is
solely due to enzyme turnover (Figure 3.19).
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Figure 3.18. Chanoclavine-I-aldehyde 7 standard curve on LC-MS displaying
concentration and peak area response. The concentration of the chanoclavine-I-aldehyde
7 standard was determined based on UV absorbance at 225 nm using the extinction
coefficient (30,900 M-1 cm' at 225 nm). The concentrations 100-500 nM represent the
full range of chanoclavine-I-aldehyde 7 substrate that was analyzed by mass
spectrometry, after quenching and dilution of the enzyme assay reaction.
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Figure 3.19. Stability of chanoclavine-I-aldehyde 7 (5 gM) under assay conditions with
boiled inactive EasAAf (2.5 nM) and NADPH (500 [M) over a time course.
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Large scale enzymatic preparation of EasAAf product cyclic iminium product 9
and subsequent synthetic reduction to yield festuclavine 11
A total of 7 x 1 mL reactions of chanoclavine-I-aldehyde 7 (1 mM), NADPH (5
mM), and EasAAf (6 pM) were allowed to react for 10 minutes prior to quenching with
NaCNBH 3 (5 mM). The reaction solutions were combined and extracted three times with
ethyl acetate 1:1 (v/v), then centrifuged at 17,000 x g for 15 min to pellet protein
precipitates. The combined organic fractions were filtered and evaporated to dryness. The
concentrated reduced enzymatic product festuclavine 11 was purified by preparative
HPLC.
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Cloning, overexpression, and purification of Aspergillusfumigatus EasG
The easG gene from A. fumigatus was PCR amplified using A. fumigatus cDNA.
Primers were designed based on the nucleotide sequence of easG from the NCBI
database (XM_751041). A pair of oligonucleotide primers were used to amplify the easG
gene: forward primer 5'- TTGGCCATATGACTATCCTCGTGCTGGGTGGCCGCG-3'
(with NdeI restriction site in bold) and reverse primer 5'-
GAAAGCTTATGCCGCATCCAGCGCGCTTTTTCC -3' (HindlIl restriction site in
bold). The PCR amplified easG gene was inserted into pGEM-T vector (Promega) for
propagation and sequencing. Subsequently, the easG sequence was excised from pGEM-
T by restriction digest and ligated into the NdeI/HindIII site of pET-24a(+) (Novagen)
expression vector as a C-His6 tagged construct.
Expression was carried out in E. coli BL-21(DE3) cells grown in LB medium
supplemented with kanamycin (50 tg/mL). Cells were grown to an OD 6 00 of 0.7 prior to
induction with IPTG (5 pM) and grown for 60 hours at 15 0C prior to harvesting. Cells
were resuspended in buffer (20 mM Tris-HCl, 300 mM NaCl, 10% (v/v) glycerol, pH =
8.0) and incubated on ice for 30 minutes with added lysozyme (1 mg/mL) and DNAseI
(10 pg/mL) then lysed by sonication. Cellular debris was pelleted by centrifugation
(15,000 x g for 1 hour). Crude EasG enzyme was purified by incubating with Ni-NTA
agarose (Qiagen). Fractions containing pure EasG, as demonstrated by SDS-PAGE
(Figure 3.19), were collected and buffer exchanged (50 mM K2HPO 4 , 100 mM NaCl,
10% (v/v) glycerol, pH = 7.0). The yield of EasG was estimated by Bradford assay as 6
mg/L culture. Final purified EasG enzyme stock concentration was 20 pM.
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Figure 3.20. SDS-PAGE of EasG (A. fumigatus) (32 kDa)
* 1 2 3 4 5 6 7 8 9 10 11 12 13 14 * 15 16 17 18 19 20 21 22 23
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1. column flow-through
2-3. buffer wash 10 mM imidazole
4. 25 mM imidazole
5-11. 50 mM imidazole
12-19. 100 mM imidazole
20-23. 150 mM imidazole
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Endpoint assays for EasAAf and EasG
Endpoint assays involved incubating EasAAf (0.1 pM), EasG (0.1 pM),
chanoclavine-I-aldehyde 7 (10 pM), and NADPH (500 pM) in 100 mM K2HPO4 buffer
(pH = 7.0) at 25 0C for 30 min. Aliquots (3 ptL) were quenched by dilution in 0.1%
formic acid in water and analyzed by LC-MS.
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Results and Discussion
Heterologous expression of EasAAf and characterization of the bound flavin
The putative flavin dependent oxidoreductase OYE homologue easA of the A.
fumigatus ergot gene cluster was successfully cloned and heterologously expressed in E.
coli. Soluble EasAAf protein was obtained at a concentration of 2.5 mg/L culture and
purified by Ni-NTA affinity chromatography (Figure 3.7). Purified EasAAf appears
yellow in color indicating that it co-purifies with a flavin.
The flavin co-factor was identified as non-covalently bound flavin
mononucleotide (FMN). The released flavin from EasAAf exhibits the same absorbance
maxima at 373 nm and 446 nm as the FMN standard (Figure 3.8). The identity of the
released flavin was further verified by co-migration with FMN standard by HPLC (Figure
3.9). The extinction coefficient of the purified FMN bound EasAAf was calculated by
comparing the absorbance of the bound EasAAf flavin versus the absorbance of the
flavin released after denaturation at 446 nm.34 Using the known extinction coefficient of
12,200 M-1cm~1 for free FMN at 446 nm, the extinction coefficient for the EasAAf
bound FMN was determined to be 11,500 M'cm-1 . Typically, 20 to 25% of
heterologously expressed EasAAf protein co-purified with the flavin cofactor. Attempts
at reconstitution, by adding FMN to the protein followed by dialysis, perturbed the flavin
spectra when the protein was re-isolated and did not result in greater catalytic activity.
The concentration of holoenzyme EasAAf bound with FMN used in subsequent
experiments was determined using flavin absorption. These results demonstrated that the
bound flavin of EasAAf was FMN, a defining characteristic of OYE homologues
observed in previous studies.3, 11, 14, 19,25
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Isolation of chanoclavine-I-aldehyde the proposed substrate of EasA_Af
Chanoclavine-I-aldehyde 7 was successfully isolated from a culture of A.
fumigatus easA disrupted strain, which accumulated pathway intermediate chanoclavine-
I-aldehyde 7 as described in Chapter 2. Chanoclavine-I-aldehyde 7 was purified and
isolated by HPLC (Figure 3.10). LC-MS analysis displayed a corresponding mass of m/z
255 which is the expected [M+H]* mass of chanoclavine-I-aldehyde 7 (Figure 3.12). The
identity of the isolated product was further substantiated by 1H-NMR and High
Resolution MS to be chanoclavine-I-aldehyde 7 (Figure 3.13, Table 3.1).
Functional role of EasA_Af in the reduction and cyclization of ergot pathway
intermediate chanoclavine-I-aldehyde 7 to yield a cyclic iminium intermediate 9
The conversion of chanoclavine-I-aldehyde 7 [M+H]* 255 to a compound with
[M]* 239 with a retention time at 3.4 min was observed upon the addition of EasA_Af
enzyme and NADPH (Figure 3.2 1A, B). The mass of this peak corresponded with mass
of the hypothetical downstream cyclized iminium ion intermediate 9 (Figure 3.5).
Steady state kinetic constants for EasA_Af were measured by monitoring the
disappearance of chanoclavine-I-aldehyde 7 [M+H]* 255 by LC-MS, where data were fit
to a ping-pong bi-bi kinetic model, which is typical for OYE. 2,1,21 The resulting Km
value of chanoclavine-I-aldehyde 7 and NADPH was 4.8 ± 1.1 pM and 192± 40.1 IM,
respectively, with a kcat value of 2,310 ± 282 min~'. Control experiments performed with
either boiled EasA_Af or in the absence of NADPH displayed no formation of [M]* 239
(Figure 3.22).
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High resolution mass spectrometry of the enzymatic product also corresponded to
the expected theoretical formula of compound 9 (Table 3.1). These assays demonstrated
that upon the addition of EasAAf enzyme and NADPH, the alkene of chanoclavine-I-
aldehyde 7 [M+H] 255 was reduced and yielded a product with a mass corresponding to
the proposed cyclic iminium intermediate 9 [M]+ 239 (Figure 3.21B).
Furthermore, our genetic studies in Chapter 2 demonstrated that the AeasA
disruption mutant of A. fumigatus failed to accumulate downstream ergot alkaloids, while
upstream pathway intermediates chanoclavine-I 6 and chanoclavine-I-aldehyde 7
accumulated. 35 Therefore, the biochemical properties observed for purified EasAAf in
vitro is consistent with the proposed function of the easA gene product in vivo, and
demonstrated that chanoclavine-I-aldehyde 7 is the substrate of EasAAf.
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Figure 3.21. LC-MS chromatograms with selected ion monitoring.
A. Starting substrate chanoclavine-I-aldehyde 7 with expected mass of [M+H]* = 255.
B. Product resulting from incubation of EasAAf with NADPH and chanoclavine-I-
aldehyde 7 is proposed to be cyclic iminium intermediate [M]* = 239 major product 9 at
3.4 min and minor product 25 at 3.2 min. Peaks observed are hypothetical
diastereoisomers .
C. Product in chromatogram B (cyclic iminium intermediate 9) reduced with NaCNBH 3
to yield festuclavine 11 with an expected [M+H]* = 241.
D. Festuclavine 11 standard with an expected [M+H]* = 241.
A. Chanoclavine-i-aldehyde
m/z 255
B. EasAAf + Chanoclavine-l-aldehyde + NADPH Product
m/z 255
m/z 239
C. EasAAf Product + NaCNBH3 m/z 241 m/z 241
D. Festuclavine Standard
100 J
200 2.25 2.50 2.75 3.0 3.25 350 375
m/z 241 m/z 241
Time4.00 4.25 4.50 .4.75.. 5.00 5.2 5.50 57 0
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Table 3.1. Exact Mass of Compounds Determined by High Resolution MS
Deviation of
Compound Observed Theoretical Theoretical Molecular
Mass Mass from Formula
Observed
(ppm)
Chanoclavine-I-aldehyde 7 m/z 255.1500 m/z 255.1497 1.2 C16H19N2 0
[M+H]+
Cyclized iminium m/z 239.1551 m/z 239.1548 1.3 C16H19N2
intermediate 9 [M]*
Festuclavine 11 m/z 241.1704 m/z 241.1705 -0.4 C16H21N2
[M+H]+
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Figure 3.22. LC-MS chromatograms with selected ion monitoring comparing active
EasAAf with controls. Peak intensities for this set of chromatograms have been
normalized to allow relative comparison of compound masses present.
A. Starting material chanoclavine-I-aldehyde 7 [M+H]* = 255 remains in enzyme assays
with boiled, denatured EasAAf enzyme.
B. Starting material chanoclavine-I-aldehyde 7 [M+H] = 255 remains in enzyme assays
with active EasAAf with no NADPH present.
C. The cyclized iminium ion enzymatic product 9 [M]* = 239 is not observed with boiled,
denatured EasAAf enzyme.
D. The cyclized iminium ion enzymatic product 9 [M]* = 239 is not observed with active
EasAAf with no NADPH present
E. The cyclized iminium ion enzymatic major product 9 [M]* = 239 and minor product
25 [M]+ = 239 is observed with active EasAAf enzyme and NADPH present.
A. Boiled EasAAf Control m/z 255 m/z 255
C
B. EasAAf NADPH Absent Control m/z 255
100-
- m/z 255
C. Boiled EasAAf Control m/z 239
100
D. EasAAf NADPH Absent Control m/z 239
100
E. EasA_Af + Chanoclavine-l-aldehyde + NADPH m/z 239
100-
m//z 239
mz 239
2.00 2i.2 2.'50 .75 3.00 .2 5 350. 3. 75 4.00.. 4.25.. 4.50 4.75 5.0 .5.25 5.'50 5.75 6.00
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The immediate product of the chanoclavine-I-aldehyde 7 reduction was expected
to be dihydrochanoclavine aldehyde 24 [M+H]* 257 (Figure 3.5); however, accumulation
of this mass was not observed at significant levels relative to the [M]+ 239 peak. This led
us to speculate that the [M]* 239 was the cyclized iminium 9 form of
dihydrochanoclavine aldehyde [M+H]* 257 formed after free rotation about the C8-C9
bond to allow condensation of the secondary amine and aldehyde (Figure 3.5). Therefore,
the reaction of the aldehyde and amine moieties of dihydrochanoclavine aldehyde 24
was rapid and favored the formation of the cyclized iminium ion 9. Consistent with our
findings, in a later study on A. fumigatus EasA (orthologue FgaOx3) by Wallwey et al.,
an [M]+ 239 intermediate was observed in trace amounts by ESI-MS and also proposed to
be the cyclic iminium intermediate from EasAAf reduction of chanoclavine-I-aldehyde
7.24
Notably, we also observed that a minor [M]* 239 peak at a retention time of 3.2
min forms over the time course of the assay relative to the major [M]* 239 more
hydrophobic peak at 3.4 min (Figure 3.23). Although these compounds could not be
isolated in quantities sufficient for structural characterization, the observation of the two
[M]+ 239 peaks provided us with a new working hypothesis. We speculate that the peaks
were diastereoisomers 9 and 25 resulting from the possible imine-enamine
tautomerization that could occur in aqueous conditions once the major cyclic iminium
product is formed and no downstream reductase is present to reduce the intermediate to
yield festuclavine 11 (Figure 3.24). The dihydrochanoclavine aldehyde 24 [M+H]* 257,
which can undergo keto-enol tautomerization, may also be another source of the
proposed diastereotopic peaks for [M]+ 239. It remains to be determined whether the
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cyclization of the major [M] t 239 intermediate is spontaneous or enzymatically
catalyzed. Possible scenarios to explain how EasAAf may work with a downstream
reductase to facilitate reduction of the correct diastereoisomer to form festuclavine 11 are
discussed later in this chapter.
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Figure 3.23. LC-MS chromatograms with selected ion monitoring of enzyme product of
EasAAf and chanoclavine-I-aldehyde 7 substrate in presence of NADPH. Peak
intensities for this set of chromatograms have been normalized to allow relative
comparison of compound masses present.
Selected ion monitoring at m/z 255 to shows complete consumption of substrate
chanoclavine-I-aldehyde 7 [M+H] = 255. Selected ion monitoring at m/z 239 shows
formation of cyclized iminium intermediate [M]* = 239. Selected ion monitoring at m/z
241 demonstrates that the reduced product festuclavine 11 [M+H]*= 241 only forms
upon addition of NaCNBH 3.
EasAAf + Chanoclavine-I-aldehyde + NADPH Product
100,
EasAAf + Chanoclavine-I-aldehyde + NADPH Product
'00]A m/z 239
m/z 255
m/z 239
m/z 239
EasAAf + Chanoclavine-1-aldehyde + NADPH Product
100,
m/z 241
Time20 .5 25 7 .0 3.25 3.5 3.75 4.00 .2 4.50 . 7 5.00 5.25 i56 57 6.00
115
- -
-------------
Figure 3.24. Racemization of the dihydrochanoclavine aldehyde 24 via keto-enol or
imine-enamine tautomerization producing the major 9 and minor 25 diastereoisomers of
the cyclized iminium intermediate.
Dihydrochanoclavine
aldehyde
[M+H]*=257
H
H
OH
H/, H
N
H uk H
Cyclic Iminium
Intermediate
[M]*=239
H20
H
H
24
keto-enol imine-enamine
H20
25
[M+H]*=257 [M]*=239
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The cyclic iminium EasAAf product as the precursor of festuclavine
To yield further insight into the identity of this cyclic iminium intermediate [M]+
239 and to further substantiate the enzymatic activity of EasAAf, we attempted to trap
the enzyme product via synthetic reduction with sodium cyanoborohydride (NaCNBH 3).
Addition of NaCNBH 3 to the assay mixture, after EasAAf catalyzed complete
consumption of chanoclavine-I-aldehyde 7, resulted in the conversion of the major cyclic
iminium intermediate 9 [M]* 239 to the expected reduction product festuclavine 11
[M+H]*241 (Figure 3.21 C). The reduced enzymatic product co-migrated with the
festuclavine 11 standard (Figure 3.21 D). The identity of the reduced enzymatic product
was further confirmed by 1H-NMR (Figure 3.26-3.28). Furthermore, high resolution MS
of the reduced cyclic iminium intermediate was in agreement with the expected mass of
festuclavine 11 (Table 3.1). These results further substantiated that the product observed
of EasAAf reduction of chanoclavine-I-aldehyde 7 was the cyclic iminium intermediate
9.
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Figure 3.25. LC-MS chromatograms with selected ion monitoring of NaCNBH 3 trapped
cyclic iminium intermediate 9 (enzyme product of EasAAf + chanoclavine-I-aldehyde 7
+ NADPH) to yield festuclavine 11. Peak intensities for this set of chromatograms have
been normalized to allow relative comparison of compound masses present.
Selected ion monitoring at m/z 255 displays complete turnover of chanoclavine-I-
aldehyde substrate 7 [M+H]* = 255 by EasA_ Af. Mass monitoring at m/z 239 displays
complete reduction of cyclic iminium intermediate 9 [M+H]* = 239. Mass monitoring at
m/z 241 shows formation of the reduced product festuclavine 11 [M+H]= 241.
EasAAf + Chanoclavine-I-aldehyde + NADPH Product + NaCNBH3 m/z 255
10CF
0
EasA_Af + Chanoclavine-l-aldehyde + NADPH Product + NaCNBH3 m/z 239100-
EasAAf + Chanoclavine-I-aldehyde + NADPH Product + NaCNBH3 m/z 241
10 m/z241
0 2ime
2.00 2i .2 5 6 2 .50 27 .00 .25 3. 50 3.75 4.00 4.25 4.50 .7 5.00 52 55 5 .75 60
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Figure 3.27. 'H-NMR spectra of compounds used in this study. Full spectra A. EasA_-Af
Enzyme product reduced with NaCNBH 3, B. Festuclavine 11, C. Chanoclavine-I-
aldehyde 7, D. Agroclavine 10
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Figure 3.28. 'H-NMR Aromatic region A. EasAAf enzyme product reduced with
NaCNBH 3, B. Festuclavine 11, C. Chanoclavine-I-aldehyde 7, D. Agroclavine 10
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EasAAf proposed mechanism of ring D formation based on Old Yellow Enzyme
EasAAf was compared to the Old Yellow Enzyme homologue from
Saccharomyces carlsbergensis, OYE 1, which has been extensively studied and
structurally characterized.7 Mechanistic studies of OYE1 suggest that T37" and Q1 1410
residues were critical for flavin binding25, while H191 and N194 interact with NADPH. 2
Collectively, active site residues H191 and N 194, and Y196 were involved in reduction
of the substrate alkene. 2,4 Protein sequence alignments demonstrate that these OYE 1
residues align with T31, Q106, H173, N176, and Y178 of the EasAAf protein sequence
(Figure 3.1). Based on the high sequence identity of EasAAf with OYE1 (40%), a
mechanism for chanoclavine-I-aldehyde 7 reduction that is analogous to the OYE1
mechanism for reduction of a, p-unsaturated ketones and aldehydes can be proposed
(Figure 3.4 and 3.5).
Initially, binding and transfer of a hydride from NADPH to reduce the FMN of
EasAAf occurs, followed by release of NADP* to allow for binding of chanoclavine-I-
aldehyde 7 (Figure 3.5A). Subsequently, the hydride from reduced FMN is transferred to
the P carbon of chanoclavine-I-aldehyde 7, where H173 and N 176 of EasAAf would act
as hydrogen bond donors and polarize the carbonyl oxygen of chanoclavine-I-aldehyde 7
.2 The Y178 residue of EasAAf serves as a proton donor to the a carbon either
concurrently with or after transfer of the hydride to the p carbon, as in OYE 1 (Figure
3.5B). 4
In the EasAAf catalyzed reaction, the immediate reduction product
dihydrochanoclavine aldehyde 24 is believed to cyclize and form the cyclic iminium
intermediate 9, it remains an area of our future research efforts to determine whether this
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cyclization is spontaneous or enzymatically catalyzed. Some preliminary studies on site
directed mutations targeting mechanistically important EasAAf catalytic active site
residues were discussed in Chapter 6.
EasG reductase and its functional role in Ergoline Ring D formation
The putative NADPH dependent reductase easG of the A. fumigatus ergot gene
cluster was successfully cloned and heterologously expressed in E. coli. Soluble EasG
protein was obtained at 6 mg/L of culture and purified by Ni-NTA affinity
chromatography (Figure 3.19).
Assay of purified A. fumigatus EasG with chanoclavine-I-aldehyde 7, NADPH,
and EasAAf enzyme yielded a product with a mass and retention time identical to the
festuclavine standard 11 [M+H]f 241 (Figure 4.6). Identity of the festuclavine product 11
was further substantiated by high resolution MS (Table 4.1). A control experiment
consisting of heat inactivated EasG with chanoclavine-I-aldehyde 7, NADPH, and
EasAAf displayed production of the cyclic iminium intermediate 9 with mass of [M]*
239 as expected (Figure 4.6). It follows from these observations that EasG facilitates the
transfer of a hydride to reduce the cyclic iminium intermediate that is produced by
EasAAf demonstrating that EasAAf and EasG were required in order to form
festuclavine 11. Recent work by Wallwey et al. to characterize the EasG orthologue
(fgaFS) from A. fumigatus further substantiates that this NADPH dependent reductase is
needed to facilitate the conversion of the EasAAf product, cyclic iminium intermediate
9, to festuclavine 11 (Figure 3.29).
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From our studies, two scenarios relating to the in vivo function of EasA_Af
toward producing festuclavine 11 may be inferred. If the cyclization were enzymatically
catalyzed, the released cyclized iminium ion 9 would be efficiently incorporated and
reduced by a downstream reductase EasG enzyme to create festuclavine 11. If the
cyclization were not enzymatically driven, the released EasAAf product would be
dihydrochanoclavine aldehyde 24, which could undergo subsequent tautomerization and
cyclization under equilibrium conditions producing two diastereoisomers (Figure 3.23).
In this scenario, the downstream iminium reductase EasG that forms festuclavine 11
would presumably only recognize the correct diastereomer of the cyclized iminium ion 9.
It also remains a possibility that EasA_Af and EasG were associated with one
another to foster the delivery of intermediate 9 from the active site of EasA to EasG, so
that racemization is minimized. Approaches to study possible protein-protein interaction
between EasAAf and EasG enzymes will be further discussed in Chapter 6.
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Figure 3.29. Proposed functional roles of EasAAf and EasG in the conversion of
chanoclavine-I-aldehyde 7 to festuclavine 11. Expected [M+H]* masses of pathway
intermediates are displayed.
H: Tyrosine
H-O
EasAAf
Chanoclavine-I-aldehyde
[M+H]* = 255
H20
EasG H
'H
11
Festuclavine
[M+H]* = 241
9
Cyclized Iminium
[M]* = 239
24
Dihydrochanoclavine
aldehyde
[M+H]* = 257
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Conclusion
This chapter describes the functional characterization of A. fumigatus enzymes
EasA and EasG that were involved in the formation of ring D in ergot alkaloid
biosynthesis. This study demonstrated that EasAAf facilitates the reduction of the
alkene in chanoclavine-I-aldehyde 7 allowing for free rotation about the C8 and C9 bond
followed by the intramolecular condensation of the secondary amine and aldehyde
moieties to form the cyclic iminium intermediate 9 (Figure 3.5B, Figure 3.29). However,
it remains a point of interest to study whether the cyclization of dihydrochanoclavine
aldehyde 24, the immediate product expected of EasAAf reduction, into the cyclic
iminium intermediate 9 is spontaneous or enzyme catalyzed.
Our results from the in vitro biochemical characterization of EasAAf enzyme
coincided with our observations from our in vivo study on the accumulation of
chanoclavine-I 6 and chanoclavine-I-aldehyde 7 in the easA gene disrupted A. fumigatus
mutant in Chapter 2, thereby further substantiating that chanoclavine-I-aldehyde 7 is the
substrate of EasAAf.
This study also demonstrated that EasG, an NADPH dependent oxidoreductase,
along with EasAAf were required to form festuclavine 11 from substrate chanoclavine-
I-aldehyde 7. Therefore, EasG acts directly after the reduction of chanoclavine-I-
aldehyde 7 by EasAAf (Figure 3.29). It remains a point of interest to study how and
whether EasAAf and EasG interact to form festuclavine. Furthermore, the successful
cloning and expression of active EasG from A. fumigatus proved to be instrumental
toward our efforts in studying the origins of structural divergence in ergot alkaloid
biosynthesis.
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The work in this chapter highlights a new role for an OYE homologue in natural
product biosynthesis. This work provided functional insight into enzymes EasAAf and
EasG, and their role in catalyzing the critical D ring cyclization of festuclavine 11 in
ergot alkaloid producing fungi.
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Chapter 4 . Controlling Pathway Divergence in Ergot Alkaloid
Biosynthesis
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Introduction
The ergot biosynthetic gene clusters of A. fumigatus and Clavicipitaceous fungi C.
purpurea and N. lolii share a set of homologous genes that were associated to early
pathway of ergot alkaloid biosynthesis (Figure 1.5). This shared set of homologous genes
across the divergent fungal species were attributed to the early steps of ergoline
biosynthesis up to the cyclization of the ring D (Figure 1.4).1 The A. fumigatus EasAAf
and EasG ergot alkaloid biosynthetic enzymes were functionally characterized and shown
to play a key role in the formation of ring D, producing festuclavine 11 from the
chanoclavine-I-aldehyde 7 as described in Chapter 3.2, 3 These findings correlate with the
observation that A. fumigatus produces festuclavine 11 and its derivatives the
fumigaclavines A 18, B 19, and C 14. Whereas Clavicipitaceous fungi C. purpurea and
N. lolii produce only agroclavine 10 derived lysergic acid amides and ergopeptides
(Figure 1.3).4~7
From a mechanistic standpoint, in order to produce the downstream ergot
alkaloids unique to each fungal species, A. fumigatus EasAAf functions as a reductase in
which the C8-C9 alpha beta double bond of chanoclavine-I-aldehyde 7 is reduced and
remains a single bond in the cyclized festuclavine 11 ring D (Figure 4.1). In contrast, the
C. purpurea or N. lolii EasA would be expected to function as an isomerase, where the
C8-C9 double bond of chanoclavine-I-aldehyde 7 is preserved but displays the opposite
geometrical configuration in the cyclized agroclavine 10 ring D (Figure 4.1).
The cyclization of chanoclavine-I-aldehyde 7 to agroclavine 10 via the
isomerization of the C8-C9 alkene has been previously suggested based on isotope
feeding studies to cultures of Claviceps (Figure 4.2). 8-13 The results of these studies
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demonstrated that the conversion of chanoclavine-I-aldehyde 7 to agroclavine 10
involved a cis-trans isomerization. Yet the exact mechanism by which agroclavine 10
was formed from chanoclavine-I-aldehyde 7 remained speculative.
Protein sequence alignments for homologues of reductase type EasA (festuclavine
producers) and isomerase type EasA (agroclavine producers), displays a significant trend.
Reductase type EasA enzymes such as A. fumigatus EasA_Af described in Chapter 3 has
a catalytic active site tyrosine, whereas isomerase type EasA such as N. lolii EasA_NI has
a phenylalanine in the same position (Figure 4.3). Notably, other catalytically important
active site residues were generally well conserved between the two enzymes.3
Given the proposed role of the catalytic tyrosine to protonate C8 upon hydride
transfer to the C9 position in reductase type EasA, we speculated that for isomerase EasA
the lack of this proton donating tyrosine would allow enolate formation followed by bond
rotation, and finally re-oxidation of the C8-C9 double bond prior to ring D formation
(Figure 4.1).
Further evidence regarding the importance of these tyrosine and phenylalanine
residues in the active site comes from our augmentation of reductase type easA with
isomerase type easA from C. purpurea in vivo as presented in Chapter 2. Replacement of
the reductase with isomerase easA in A. fumigatus, demonstrated a switch in ergot profile
from the production of festuclavine 11 to agroclavine 10 derived alkaloids.3
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Figure 4.1. Proposed pathway branch point of ergot alkaloid biosynthesis in divergent
fungal species. Common intermediate chanoclavine-I-aldehyde 7 is converted via N. lolii
EasA (EasANi) by isomerization of the C8-C9 alkene to eventually yield agroclavine
10. Alternatively chanoclavine-I-aldehyde 7 is converted in A. fumigatus EasA
(EasAAf) by reduction of the C8-C9 alkene to eventually yield festuclavine 11.
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Figure 4.2. Early isotope feeding studies suggest that two cis-trans isomerizations
occuring, the first between DMAT 3 and chanoclavine-18 6 and second between
chanoclavine-I 6 and agroclavine 10. 5,6,9-13
() indicates 14C label of [2- 14C] mevalonate feeding study conducted by Fehr et al.9
(*) indicates 14 C label of [Z-14CH 3] DMAT feeding study conducted by Pachlatko et al.8
Note: Molecules drawn with double labels represent the superposition of two individual
single labeled downstream molecules that were observed in separate feeding studies.
They indicate where the upstream labeled precursor were incorporated into the
downstream products.
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Figure 4.3. Alignment of partial EasA sequences from several ergot alkaloid producing
fungi. Fungi that produce festuclavine derivatives are underlined; fungi that produce
agroclavine derivatives have no underline. The Tyr-Phe (Y-F) mutation across fungi that
correlates with production of festuclavine 11 versus agroclavine 10 are indicated by
symbol : . Mechanistically important EasA residues based on the mechanism of 1 OYA of
S. carlsbergensis are indicated by symbols * or .14-18
Corresponding accessions: A. fumigatus (XP 756133); C. africana (HM535795); C.
gigantea (HM535794); N. lolii (ABM91449); Epichloefestucae (scaffold 00549,
http://lims.ca.uky.edu/2368blast/blast.html); C. purpurea strain P1 (CAG28312); C.
purpurea A2 strain ATCC20102 (HM535793); and C. fusiformis (ABV57819).
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In this chapter we describe the cloning, expression, and functional
characterization of N. lolii isomerase type EasA (EasANi) and its catalytic role in the
cyclization of ring D in the presence of A. fumigatus EasG NADPH dependent reductase
(described in Chapter 3) to produce agroclavine 10. This set of in vitro experiments
served to complement our study in Chapter 2, where the augmentation of the reductase
type easA gene in A. fumigatus by isomerase type easA from C. purpurea in vivo
provided a switch from festuclavine 11 to agroclavine 10 derived alkaloid production in
cultures.3 To gain further insight into the distinct functional roles of reductase versus
isomerase type EasA, we used mutational analysis to provide a mechanistic rationale to
explain how EasA can control this critical branch point in ergot alkaloid biosynthesis.
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Experimental Methods
General Materials and Methods
General recombinant DNA cloning procedures were performed using pGEM-T
vector (Promega) and propagated in E. coli Top10 (Invitrogen). Protein expression for N.
lolii EasA was conducted in E. coli Rosetta (DE3) pLysS (Novagen). Protein expression
for EasG was conducted in E. coli BL-21 (DE3) (Invitrogen). PCR amplification utilized
Platinum Taq DNA Polymerase (Invitrogen). Recombinant DNA plasmids were prepared
using Qiaprep Spin Miniprep and Qiaquick Gel Extraction kits (Qiagen). Restriction
enzymes and T4 DNA ligase were purchased from New England Biolabs. Primers for
cloning were synthesized by Integrated DNA Technologies and DNA sequencing was
conducted by the MIT Biopolymers Laboratory (Cambridge, MA).
LC-MS analysis was conducted using an Acquity Ultra Performance BEH C 18
column with a 1.7 mm particle size, 2.1 x 100 mm dimension, with a gradient of
acetonitrile/0.1% formic acid in water mobile phase (10:90 to 20:80 from 0-5 min, 20:80
to 90:10 from 5-6 min, and 90:10 to 10:90 from 6-7 min at a constant flow rate of 0.5
mL/min). The column elution was coupled to MS analysis carried out using a Micromass
LCT Premier TOF Mass Spectrometer with an ESI source (Waters). Accurate mass data
were acquired using reference compound leucine enkephalin for lock mass correction. A
Varian Cary 50 Bio Scanning Spectrometer was used to acquire UV-Vis spectra. The
chanoclavine-I-aldehyde 7 substrate was isolated from the AeasA deletion strain of A.
fumigatus in Chapter 3 and as previously described.'
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Cloning, overexpression, and purification of Neotyphodium lolii EasA
The N. lolii easA gene was PCR amplified using N. lolii genomic DNA supplied
by Daniel Panaccione. Primers were designed based on the nucleotide sequence of N.
lolii easA from the NCBI database (EF 125025.1). The following pair of oligonucleotide
primers were used to amplify the easA gene: forward primer 5'-
TTGGCCATATGTCAACTTCAAATCTTTTCACGCCGC-3' (with NdeI restriction site
in bold) and reverse primer 5'- GACTCGAGTGCTAGAACTGCCTGCTTCTTGTTC-
3' (XhoI restriction site in bold). The PCR amplified easA gene was inserted into pGEM-
T vector (Promega) for propagation and sequencing. Subsequently, the easA sequence
was excised from pGEM-T by restriction digest then ligated into the NdeI/XhoI site of
pET-24a(+) (Novagen) expression vector as a C-His6 tagged construct.
The F176Y mutant of N. lolii easA was constructed using the Quickchange II Site
Directed Mutagenesis Kit (Stratagene). The following pair of oligonucleotide primers
were used: forward primer 5'-
TCCACGGTGCCAATGGATATCTCATCGATCAGTTT-3' and reverse primer 5'-
AAACTGATCGATGAGATATCCATTGGCACCGTGGA-3'.
EasAAf_Y178F expression was conducted according to the method described in
Chapter 3 for expression of EasAAf.' The Y178F mutant of A. fumigatus easA was
constructed using the Quickchange II Site Directed Mutagenesis Kit (Stratagene). The
following pair of oligonucleotide primers were used: forward primer 5'-
CATGGTGCCAATGGGTTCCTCATCGACCAGT-3' and reverse primer 5'-
ACTGGTCGATGAGGAACCCATTGGCACCATG-3'.
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Expression for both wild type and mutant N. loii EasA was carried out in LB
medium supplemented with kanamycin (50 pg/mL) and chloramphenicol (34 ptg/mL).
Rosetta (DE3) pLysS cells were grown to an OD 600 of 0.7 prior to induction with IPTG (1
mM) and grown for 30 hours at 15 0C prior to harvesting. Cells were resuspended in
buffer (20 mM Tris-HCl, 300 mM NaCl, 10% (v/v) glycerol, pH = 8.0) and incubated on
ice for 30 mins with added lysozyme (1 mg/mL) and DNAseI (10 pg/mL) and lysed by
sonication. Cellular debris were pelleted by centrifugation (15,000 x g for 1 hr). EasA
enzyme was purified using Ni-NTA agarose (Qiagen).
Previous work established that all OYE homologs as well as EasA from A.
1-8fumigatus co-purifies with an FMN flavin cofactor as discussed in Chapter 3. - The yield
of active holoenzyme EasA from N. loii wild type EasA (EasANl) and N. lolii EasA
F176Y mutant (EasA_Ni_F176Y) were both estimated to be 0.3 mg/L culture by
measuring the UV absorbance of flavin at 446 nm (FMN extinction coefficient of 12,200
M'1cm%).1 9 Assays were conducted with enzyme that eluted in the 50 mM imidazole
fractions from the Ni-NTA agarose column (Figure 4.4). The enzyme in these fractions
co-purified with flavin cofactor. Final EasANl holoenzyme stock concentration was at 6
pM. Enzyme eluted in the 150-300 mM imidazole fractions lacked the flavin cofactor as
evidenced by UV-Vis spectra (Figure 4.5). These fractions were also shown to convert
chanoclavine-I-aldehyde 7 to agroclavine 10 when assayed with added FMN (1 pM) and
apoenzyme EasA_Nl (0.1 pM).
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Figure 4.4. SDS-PAGE of EasA (N. lolii) (42 kDa)
* 1 2 3 4 5 6 7 8 9 10 11 12 13
*. NEB Broad Range Protein Ladder (2-212 kDa)
1. column flow-through
2. buffer wash 10 mM imidazole
3. 25 mM imidazole
4-6. 50 mM imidazole
7. 100 mM imidazole
10-12. 150 mM imidazole
13. 300 mM imidazole
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Figure 4.5. Flavin absorbance spectrum (300 nm to 550 nm).
A. EasA_Nl co-purified with FMN
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C. EasA_NI apoenzyme
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Cloning, overexpression, and purification of Aspergillusfumigatus EasG
The easG gene from A. fumigatus was cloned and heterologously expressed
according to the methods and materials section in Chapter 3.
Endpoint assays for EasA and EasG
Endpoint assays incubated EasAAf, EasA_Nl, and EasA mutants (0.1 pM, final
concentration) with EasG (0.1 pM, final concentration), chanoclavine-I-aldehyde 7 (10
gM, final concentration), and NADPH (500 pM, final concentration) in 100 mM K2HPO4
buffer (pH = 7.0) at 25 C for 30 min. Aliquots (3 ptL) were quenched by dilution in 0.1%
formic acid in water and analyzed by LC-MS.
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Results and Discussion
Heterologous expression of EasA_NI and characterization of the bound flavin
The putative flavin dependent oxidoreductase OYE homologue easA of the N.
lolii ergot gene cluster was successfully cloned and heterologously expressed in E. coli.
Crude EasA_Nl was purified by Ni-NTA affinity chromatography to yield holoenzyme
EasA_Nl at 0.3 mg/L culture (Figure 4.4). EasA_Nl, which eluted in the 50mM
imidazole fractions from the Ni-NTA agarose column, appeared yellow in color while
enzyme eluting in the 150-300 mM imidazole fractions appeared colorless. UV-Vis
spectrophotometry demonstrated that the yellow fractions contained EasA_N1 that co-
purified with flavin cofactor, while colorless enzyme, eluting in the 150-300 mM
imidazole fractions, lacked flavin. The flavin that co-purified with EasA_Nl was
identified as flavin mononucleotide (FMN) and exhibited the same absorbance maxima at
373 nm and 446 nm as the FMN standard (Figure 4.5). Active EasA_Nl holoenzyme
concentration was measured by UV absorbance of flavin at 446 nm based on the FMN
extinction coefficient of 12,200 M~cm~1.19 Assays were conducted with EasA_N1 enzyme
that co-purified with FMN (50 mM imidazole fractions). EasA_Nl that did not co-purify
with FMN (100-300 mM) was also active toward the conversion of chanoclavine-I-
aldehyde 7 to agroclavine 10 when assayed along with added FMN (1 pM) to apoenzyme
EasANl (0.1 pM), though displayed a much slower rate of turnover qualitatively.
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The functional role of EasANl isomerase
When assayed with EasA_Nl and NADPH, the chanoclavine-I-aldehyde 7
[M+H]* 255 peak decreased over time. Unlike EasAAf that accumulated the cyclic
iminium intermediate 9 with a peak corresponding to [M]* 239 (Figure 4.6), the EasA_Ni
did not accumulate any intermediate species in significant yield as evidenced by LC-MS
(Figure 4.7). It was expected that EasA_Ni would accumulate the proposed intermediate
8 [M]+ 237 with its expected isomerase type activity (Figure 4.1), however the
chromatograms of EasA_Nl, inactive boiled EasG, NADPH, and chanoclavine-I-
aldehyde 7 did not show significant accumulation of this selected ion mass (Figure 4.8).
We hypothesized that the [M]+ 237, if formed, may not have accumulated in adequate
amounts to allow for detection by LC-MS. The instability of the [M]* 237 hypothetical
cyclized iminium intermediate may arise from its reactivity as a Michael acceptor to
undergo possible 1,4 addition with nucleophiles such as protein side chains.
Synthetic reduction with NaCNBH3 and NaCNBD 3 of assays consisting of the
immediate product of EasA_Nl turnover of chanoclavine-I-aldehyde 7 did not yield any
trapped product in significant amounts that were identifiable by mass spectrometry
(Figure 4.9). This provided additional evidence that the immediate product of EasA_Ni
was unique from the cyclized iminium produced by EasAAf intermediate catalyzed
reduction of chanoclavine-I-aldehyde 7.
To further investigate the functional role of EasA_Nl, we assayed this enzyme
with NADPH dependent reductase from A. fumigatus EasG (65% amino acid similarity to
N. lolii EasG, Figure 4.10), in the presence of chanoclavine-I-aldehyde 7, and NADPH.
Gratifyingly, these assays demonstrated the conversion of chanoclavine-I-aldehyde 7
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detected at m/z 255 to a compound with a mass m/z 239 and retention time that was
identical to the agroclavine standard 10 (Figure 4.11). High resolution mass data of the
EasANl and EasG product were also identical to the expected theoretical mass of
agroclavine 10 (Table 4.1).
Additionally we noted that the product with [M+H]* 239, resulting from
EasANl and EasG, was different from the proposed cyclic iminium intermediate 9 of
EasAAf with the same mass [M]* 239, as these two compounds display different
retention times (Figure 4.6 and 4.7). The EasANl and EasG agroclavine product also
showed no decrease in product intensity over prolonged incubation of 12 hours, as
opposed to the gradual degradation of the cyclic iminium intermediate 9 produced by
EasAAf over the same time interval.
To further substantiate the identity of agroclavine 10 from the cyclized iminium
intermediate 9, we subjected the product of EasA_Nl and EasG to synthetic reduction
with NaCNBH 3 or NaCNBD 3, which resulted in no change in mass (Figure 4.12). In
contrast, synthetic reduction using NaCNBH3 or NaCNBD 3 of the immediate product of
EasAAf, the cyclic iminium intermediate 9 with m/z 239, resulted in formation of
products with masses consistent with festuclavine 11 at m/z 241 and singly deuterated
festuclavine at m/z 242 (Figure 4.9).
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Figure 4.6. LC-MS chromatograms with selected ion monitoring comparing active
EasAAf + EasG with controls. Peak intensities for this set of chromatograms have been
normalized to allow relative comparison of compound masses present.
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B. The cyclized iminium ion enzymatic product 9 [M]* = 239 was observed in the
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Figure 4.7. LC-MS chromatograms with selected ion monitoring comparing active
EasA_NI + EasG with controls. Peak intensities for this set of chromatograms have been
normalized to allow relative comparison of compound masses present.
A. Substrate chanoclavine-I-aldehyde 7 [M+H] = 255 remains in enzyme assays with
boiled EasA_NI enzyme and active EasG
B. Negligible products observed. Also see Figure 4.8C, D traces [M]+ = 237 and 239
C. Agroclavine 10 with [M+H]* = 239 was observed with active EasA_Ni and EasG.
D. Agroclavine 10 standard [M+H]*= 239
E. Festuclavine 11 standard [M+H]*= 241
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Figure 4.8. LC-MS chromatograms with selected ion
monitoring for comparison of intermediates produced
exclusively by EasAAf, EasA_Ni, or EasA_NiF 76Y
with boiled EasG. Selected ion monitoring of iminium
intermediates with expected masses [M]* = 239 and
[M]* = 237. Peak intensities for this set of
chromatograms have been normalized to allow relative
comparison of compound masses present.
9 8
Iminium Iminium
[M]-239 [M]-237
A. Selected ion monitoring at m/z 239 of EasAAf + boiled EasG.
Observed cyclic iminium intermediate 9 with mass [M]+ = 239.
B. Selected ion monitoring at m/z 237 of EasAAf + boiled EasG.
Cyclic iminium intermediate 8 with mass [M]= 237 not observed.
C. Selected ion monitoring at m/z 239 of EasA_NI + boiled EasG.
Cyclic iminium intermediate 9 with mass [M]*= 239 not observed.
D. Selected ion monitoring at m/z 237 of EasA_NI + boiled EasG.
Cyclic iminium intermediate 8 with mass [M]*= 237 not observed.
E. Selected ion monitoring at m/z 239 of EasA_NI_F176Y mutant +
Observed cyclic iminium intermediate 9 with mass [M]+ = 239.
F. Selected ion monitoring at m/z 237 of EasA_NI F176Y mutant +
Cyclic iminium intermediate 8 with mass [M] = 237 not observed.
A. EasAAf + Boiled EasG + Chanoclavine-l-aldehyde + NADPH
100- m/z 239
B. EasAAf + Boiled EasG + Chanoclavine-l-aldehyde + NADPH
100-
boiled EasG.
boiled EasG.
mlz 239
m/z 237
C. EasANI + Boiled EasG + Chanoclavine-l-aldehyde + NADPH
100-
D. EasA_NI + Boiled EasG + Chanoclavine-l-aldehyde + NADPH
100-
E. EasA_NI_F176Y + Boiled EasG + Chanoclavine-I-aldehyde + NADPH
100-
m/z 239
F. EasA_NI_F176Y + Boiled EasG + Chanoclavine-l-aldehyde + NADPH100-
m/z 239
m/z 237
m/z 239
m/z 237
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Figure 4.9. LC-MS D
chromatograms with selected H H H,,
ion monitoring comparing N
active EasAAf, EasA_Ni, and w I
EasA NI F176Y with boiled HN HN HN
EasG with added NaCNBH 3 or 10 11 Deuterated
NaCNBD 3 to observe reduced Agroclavine Festuclavine Festuclavine
intermediate masses. Peak [M+H]* 239 [M+H]* 241 [M+H] 242
intensities for this set of chromatograms have been normalized to allow relative
comparison of compound masses present.
A. Festuclavine 11 [M+H]* = 241 was observed, consistent with the NaCNBH 3 reduction
of the cyclic iminium intermediate at mass [M]+ = 239.
B. Singly deuterated festuclavine [M+H]* = 242 was observed, consistent with the
NaCNBD 3 reduction of the cyclic iminium intermediate 9 at mass [M]* = 239.
C. Negligible products observed.
D. Negligible products observed.
E. Festuclavine 11 [M+H]* = 241 was observed, consistent with the NaCNBH3 reduction
of the cyclic iminium intermediate at mass [M]*= 239.
F. Singly deuterated festuclavine [M+H]* = 242 was observed, consistent with the
NaCNBD 3 reduction of the cyclic iminium intermediate 9 at mass [M]*= 239.
G. Festuclavine standard [M+H]* = 241
m/z 239 + 241 + 242
A. EasA_Af + Boiled EasG + Chanoclavine-l-aldehyde + NADPH + NaCNBH3
100-_
m/z 241
B. EasAAf + Boiled EasG + Chanoclavine-l-aldehyde + NADPH + NaCNBD3
1007 _
m/z 242
C. EasA_NI + Boiled EasG + Chanoclavne-l-aldehyde + NADPH + NaCNBH3
.
D. EasANl + Boiled G + Chanoclavine-1-aldehyde + NADPH + NaCNBD3
100
E. EasANIF176Y + Boiled G + Chanoclavine-l-aidehyde + NADPH + NaCNBH3
1007
m/z 241
F. EasAN3_F176Y + Boiled G + Chanoclavine4-aldehyde + NADPH + NaCNBD3
100-
m/z 242
G. Festuciavine 
z241007mz 
151
-- -- -------- . .......
Figure 4.10. Alignment of EasG sequences.
Accessions: A. fumigatus EasG, XM_751041; N. lolii EasG, EF125025.1.
EasG Af XM 751041
EasGNlEF125025.1
EasG Af XM 751041
EasGNl EF125025.1
EasG Af XM 751041
EasGNlEF125025.1
EasG Af XM 751041
EasGNlEF125025.1
EasG Af XM 751041
EasGNiEF125025.1
EasG Af XM 751041
EasG Nl EF125025.1
---------------------MTILVLGGRGKTASRLSLLLDNAGVPFLVGSSST--SYV 37
MVQIYLPRLSMRLGYHDKNNKMTILLTGGRGKTASHIASLLQAAKVPFIVASRSSDPSSS 60
****. ********. .. **. * ***.* * *. *
GPYKMTHFDWLNEDTWTNVFLRASLDGIDPISAVYLVGGHAPELVDPGIRFINVARAQGV 97
SPYYQNCFDWLDEKTYGDVLT--SKDSMQPISTIWLVPPPIFDLAPLMIKFVDFASRKGV 118
** ****.* *. .*. * * .. ***...** .* *.*.. * .**
NRFVLLSASNIAKGTHSMGILHAHLDSLEDVQYVVLRPTWFMENLLEDPHVS--WIKKED 155
KRFVLLSASTIKKGGPAMGQVHEYLASLGGIEYAVLRPTWFMENFSYPQELQRLAIKNEN 178
.******** * ** .** .* .* ** . .* **********. . *..
KIYSATGDGKIPFISADDIARVAFSVLTEWKSQRAQEYFVLGPELLSYDQVADILTTVLG 215
KIYSAAGDGKLPFVSVADIARVAFRTLTDEKS-HNTDYVLLGPELITYDQVAETLSTVLG 237
RKITHVSLAEADLARLLRDDVGLPPDFAAMLASMETDVKHGTEVRNSHDVKKVTGSLPCS 275
RTITHIKLTEEELVKRL-ENSGMPAEDAKMLAGMDTSISDGAEDRLNNVVKHVTGADPRT 296
FLDFAEQEKARWMRH 290
FLDFATHQKATWG-- 309
152
Figure 4.11. LC-MS chromatograms with select ion monitoring at m/z 239 and 241
displays products of EasAAf, EasA_Ni, and EasA_Ni_F 1 67Y with EasG.
A. EasAAf + EasG + Chanoclavine-I-aldehyde 7 + NADPH
B. EasA_NI + EasG + Chanoclavine-I-aldehyde 7 + NADPH
C. EasA_NI _FI76Y + EasG + Chanoclavine-I-aldehyde 7 + NADPH
D. Agroclavine standard 10 [M+H]* = 239
E. Festuclavine standard 11 [M+H] = 241
10 11
Agroclavine Festuclavine
[M+H]* 239 [M+H]* 241
m/z 239 + 241
A. EasAAf +EasG
100-
m/z 241
B. EasANI + EasG
100 
_
m/z 239
C. EasANIF176Y + EasG
100]
D. Agroclavine
100-
m/z 239 m/z 241
m/z 239
&
E. Festuclavine
100- m/z 241
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Table 4.1. Exact Mass of Compounds Determined by High Resolution MS
154
Deviation of
Theoretical
Compound Observed Theoretical from Molecular
Mass Mass Observed Formula
Mass (ppm)
EasA Af + EasG Product m/z 241.1695 m/z 241.1705 -4.1 Ci6H21N2
Festuclavine 11 [M+H]+
EasANl + EasG Product m/z 239.1541 m/z 239.1548 -2.9 Ci6H19N2
Agroclavine 10 [M+H]+
EasA_Ni_F176Y + EasG m/z 239.1556 m/z 239.1548 3.3 Ci6H19N2
Product
Agroclavine 10 [M+H]+
EasANiF176Y + EasG m/z 241.1708 m/z 241.1705 1.2 Ci6H21N2
Product
Festuclavine 11 [M+H]+
Figure 4.12. LC-MS chromatograms with selected ion monitoring comparing active
EasAAf, EasA_Ni, and EasA_Ni_Fl 76Y with EasG with added NaCNBH 3 or
NaCNBD 3 to display no reaction with enzyme products. Peak intensities for this set of
chromatograms have been normalized to allow relative comparison of compound masses
present.
H,, H,,H'' N H'' N
| H H
HN HN
10 11
Agroclavine Festuclavine
[M+H]* 239 [M+H]* 241
A.) Festuclavine 11 [M+H]* = 241 was observed.
B.) Festuclavine 11 [M+H]* = 241 was observed.
C.) Agroclavine 10 [M+H]* = 239 was observed.
D.) Agroclavine 10 [M+H]* = 239 was observed.
E.) Festuclavine 11 [M+H]* = 241 and agroclavine [M+H]* = 239 was observed.
F.) Festuclavine 11 [M+H]* = 241 and agroclavine [M+H]* = 239 was observed.
G.) Festuclavine standard 11 [M+H]* = 241
H.) Agroclavine standard 10 [M+H]* = 239
m~z 239 +241 +242
A. EasAAf + EasG + Chanoclavine-1-aldehyde + NADPH + NaCNBH3
1 m/z 241
B. EasAAf + EasG + Chanoclavine-I-aldehyde + NADPH + NaCNBD3
1 A 
m/z 241
C. EasANI + EasG + Chanoclavine--aldehyde + NADPH + NaCNBH3
1 Am/z 239
D. EasANI + EasG + Chanoclavine-I-aldehyde + NADPH + NaCNBD3
1 m/dz 239
E. EasANIF176Y + EasG + Chanocavine-1-aldehyde + NADPH + NaCNBH3
100
d m/z 239 m/z 241
F. EasANIF176Y + EasG + Chanoclavine-1-aldehyde + NADPH + NaCNBD3
100 m/z 239 m/z 241
G. Agroclavine
10 m/z239
H. Festuciavine m/z 24110
.
00 308 .00 5ime3.0 .20 340 360 380 40 4k 20 40 4k 60 4.80 5.00 5.2,0 5.40 .... b .5'.8'0...6.00
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Observing the production of agroclavine 10 only in the presence of added EasG in
assays suggested a role for this enzyme in reducing the proposed iminium intermediate 8.
Thus, we speculated that EasG may work after or in conjunction with EasANl. It
remains a focus of our research efforts to understand the nature of this potential
interaction between EasA_Nl and EasG, and the details regarding how the proposed
cyclic iminium intermediate 8 [M]+ 237 of EasANl was stabilized or rapidly reduced by
EasG.
The collective results of these experiments supported the hypothesis that EasA_Nl
functions as an isomerase as opposed to the EasAAf reductase. Interestingly, the
function demonstrated by EasA_Nl in these in vitro assays parallel the ergot alkaloid
production profile of the N. lolii species. These results further validate that homologues
of EasA exert control over the production of either festuclavine 11 (EasAAf + EasG) or
agroclavine 10 (EasA_Nl + EasG) derived ergot alkaloids from the common pathway
intermediate chanoclavine-I-aldehyde 7.
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EasA at the branch point of ergot alkaloid biosynthesis and the mechanistic control
over pathway divergence
To achieve a better understanding of the mechanistic difference that accounted for
the production of festuclavine 11 or agroclavine 10 by the two homologues of EasA, we
compared the sequences of EasA_Ni with EasAAf as well as other EasA homologs from
both festuclavine 11 and agroclavine 10 producing fungal species (Figure 4.3). The most
intriguing trend between these sets of ergot alkaloid producers were that EasA
homologues, in fungal species which produce agroclavine 10, consisted of an active site
phenylalanine such as seen in the EasA_Nl protein sequence. In contrast, fungal species
that produce festuclavine 11 have an active site tyrosine instead, such as observed in the
protein sequence of EasAAf reductase and other OYE homologues (Figures 4.1 and
4.3).
In previous mechanistic studies of OYE, this catalytic active site tyrosine acts as a
general acid to protonate the alpha carbon position either with or after hydride donation
to the beta position of an alkene substrate, thus allowing the enzyme to function as a
reductase.16, 20 In the EasAAf reduction of chanoclavine-I-aldehyde 7, this catalytic
tyrosine was proposed to act in an analogous fashion to the OYE tyrosine residue, as
discussed in Chapter 3.2 We hypothesized that due to the substitution of this tyrosine for a
phenylalanine residue in the active site of EasANl, this enzyme was not be able to
protonate the alpha position of chanoclavine-I-aldehyde 7 after transfer of a hydride from
FMN to the C9 position; this would allow enolization of the substrate (Figure 4.1).
Subsequent rotation of the enolate around the C8-C9 position followed by
tautomerization and re-oxidation by transfer of the hydride back to the flavin would result
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in the formation of the Z alkene geometry required for D ring cyclization. The
condensation between the aldehyde and secondary amine moieties would result in the
formation of a cyclic iminium ion intermediate 8 that was a unique product of the
isomerase type EasA_Nl catalyzed reaction (Figure 4.1).
Precedence for our proposed isomerase type EasA_Nl mechanism was found in
previous isotope labeled pre-cursor feeding studies to cultures of C. purpurea an
agroclavine producer (Figure 4.13A.).2 1 The outcome of the numerous feeding
experiments by Floss and co-workers supported a mechanism that involved the
intermolecular transfer of the hydrogen at C9. 5,10,21 One of the feeding experiments that
provided the most compelling evidence to support intermolecular hydrogen transfer
involved feeding separately labeled 2H and 13C chanoclavine-I 6, the direct precursor to
chanoclavine-I-aldehyde 7, to Claviceps culture which transformed this substrate to
doubly labeled agroclavine derived ergot alkaloids (Figure 4.13B).2 1
The double labeled end product was supportive of a mechanism where the
hydrogen at C9 undergoes an intermolecular transfer from one substrate to the next. Floss
and co-workers accounted for this observation by proposing that this transfer occurs by
addition of a hydrogen at C9 followed by removal of a hydrogen, and suggesting that one
of these steps may be non-stereoselective (Figure 4.13B).s 11, 21 Likewise, we hypothesize
that EasA_Nl could act in an analogous manner (Figure 4.13A). The details of
intermolecular transfer and sequence of events of the isomerization of EasA_Ni
cyclization remain a point of focus in our future research efforts.
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Figure 4.13. Chanoclavine-I-aldehyde 7 and the isomerization of the C8-C9 alkene.
A. Proposed mechanism for isomerization of the chanoclavine-I-aldehyde 7 C8-C9
alkene by N. lolii EasA (EasA NI) involving reoxidation of the C8-C9 bond.
Intermolecular hydrogen transfer occurs when the reduced FMN binds another molecule
of chanoclavine-I-aldehyde 7.
B. Whole cell labeling studies conducted by the group of Floss ,11, 21 displayed a mixture
of double, single, and unlabelled downstream products when labeled chanoclavine-I
(direct precursor of chanoclavine-I-aldehyde 7) was fed to cultures of Claviceps. These
feeding studies suggested that the H of C9 undergoes intermolecular transfer.
R H
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0O
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Switching the activity of EasA from isomerase to reductase
To test our hypothesis regarding the association of an EasA_Nl isomerase type
mechanism with an active site phenylalanine as opposed to tyrosine, we produced an
EasA_Ni mutant with F 1 76Y substitution (EasAN_F 1 76Y) to see if we could switch
the activity from isomerase to reductase. Upon assay of EasA_Ni_F176Y with EasG,
NADPH, and chanoclavine-I-aldehyde 7 we observed substrate disappearance along with
the production of peaks with identical mass and retention time to the festuclavine 11
[M+H]* 241 and agroclavine 10 [M+H]* 239 standards (Figure 4.11). High resolution
MS of these products were consistent with theoretical masses for agroclavine 10 and
festuclavine 11 (Table 4.1). The EasA_Ni_F 1 76Y mutant production of both
festuclavine 11 and agroclavine 10, contrasted the production of only agroclavine 10 by
wild type EasA_NI (Figure 4.11).
Further substantiating evidence that EasA_Ni_F 1 76Y could produce festuclavine
11 was observed in the control assay of EasA_Ni_F 1 76Y with heat inactivated EasG.
Accumulation of the proposed cyclic iminium intermediate 9 [M]* 239 occurred in this
assay (Figure 4.14), with an identical mass and retention time to those of the EasAAf
product. Trapping the cyclic iminium intermediate of the EasA_Ni_F 1 76Y of the reaction
by synthetic reduction using NaCNBH 3 or NaCNBD 3 resulted in masses consistent with
festuclavine 11 at [M+H]* 241 and singly deuterated festuclavine at [M+H]* 242 (Figure
4.9). The products of synthetic reduction were identical in mass and retention time to the
synthetically reduced product of EasAAf.
To investigate whether a similar switch in activity from reductase to isomerase
would be observed for EasAAf, we created a mutant EasAAf with Y178F substitution
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(EasAAf _Y178F) to determine if we could observe agroclavine 10 production in
addition to festuclavine 11. Interestingly, the EasAAf_Y178F mutant when assayed
along with EasG, NADPH, and chanoclavine-I-aldehyde 7 did not accumulate
agroclavine 10 but only festuclavine 11. The overall reaction of the EasAAf_Y178F
mutant was qualitatively similar to the wild type EasAAf as they both produce
festuclavine 11 (Figure 4.15).
The results of these experiments demonstrated that the active site phenylalanine in
EasAN1 played an important role in the production of agroclavine 10. Furthermore, this
experiment substantiated that a tyrosine in this position serves as a general acid to
protonate the alpha position of chanoclavine-I-aldehyde 7 following transfer of a hydride
to the beta position, as we observe in the wild type EasAAf reductase.2 This suggested
that the tyrosine in the active site of EasA homologues plays a similar role as a general
acid like the conserved tyrosine in OYE homologues and EasAAf.16 These results were
also consistent with the in vivo augmentation of the reductase type easA of A. fumigatus
with isomerase type easA from C. purpurea, as detailed in Chapter 2, resulting in a
switch in ergot alkaloid production profile from festuclavine 11 to agroclavine 10 derived
alkaloids. 3
Notably, the observation that the EasA_Ni_F 1 76Y mutant still produces
agroclavine 10 in addition to festuclavine 11 suggested that other residues in the active
site still contribute toward the isomerization of the C8-C9 double bond. We speculated
that this may occur in EasANl by exclusion of outside proton donors such as water into
the active site or by residues that contribute to the thermodynamic accessibility of the
proposed enolate intermediate.
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Likewise, the failure of the EasAAf Y178F to show isomerase activity also
allowed us to speculate on the general active site differences between isomerase EasA_Ni
and reductase EasAAf. We propose that the EasAAf active site may be more exposed
to proton donors such as water that can protonate the C8 position, thus still allowing the
cyclic iminium intermediate 9 to form even in the absence of the tyrosine residue.
Moreover, other residues that may stabilize the proposed enolate intermediate in the
isomerase pathway (Figure 4.1) may not be present in EasAAf_Y1 78F, resulting in
reductase activity being favored over isomerase activity.
These results suggest that more extensive mutational analysis of the active site of
both isomerase and reductase type EasA were required in order to observe a complete
switch in activity. Mutational analysis and further structural characterization of product
stereochemistry will allow us to reconcile the mechanistic differences of isomerase
versus reductase EasA. Experiments to detail these mechanistic differences are discussed
in future directions Chapter 6.
Collectively, these findings demonstrated that critical active site presence of a
phenylalanine in place of a tyrosine in isomerase type EasA_Nl was responsible for its
isomerase activity, thus producing agroclavine 10 derived ergot alkaloids with an
unsaturated ring D. This finding was in contrast to the reductase type EasAAf described
in Chapter 3, where the critical active site tyrosine facilitated the production of
festuclavine 11 derived ergot alkaloids with a saturated ring D.
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Figure 4.14. LC-MS chromatograms with selected ion monitoring comparing active
EasA_NI_Fl 76Y + EasG with controls. Peak intensities for this set of chromatograms
have been normalized to allow relative comparison of compound masses present.
A.) Substrate chanoclavine-I-aldehyde 7 [M+H] = 255 remained in enzyme assays with
boiled EasA_Nl_Fl 76Y enzyme and active EasG.
B.) Starting material chanoclavine-I-aldehyde 7 [M+H]* = 255 and the cyclized iminium
ion enzymatic product 9 [M]* = 239 was observed in the presence of active
EasAAf Fl 76Y + boiled EasG.
C.) Agroclavine 10 with [M+H]* = 239 and festuclavine 11 [M+H]* = 241 was observed
with active EasA Nl Fl 76Y and EasG.
D.) Agroclavine standard 10 [M+H]*= 239
E.) Festuclavine standard 11 [M+H]*= 241
0
H NH'' N H' N H,, N
H H H H
HN HN HN HN
7 10 11 9
Chanoclavine-- Agroclavine Festuclavine Iminium
aldehyde
[M+H]* 255 [M+H]* 239 [M+H]* 241 [M]* 239
m/z 239 +241 +255A. Boiled EasA_NI_F176Y + EasG + Chanoclavine-l-aldehyde + NADPH
10C-
m/z 255
B. EasANIF176Y + Boiled EasG + Chanoclavine-l-aldehyde + NADPH
100-
m/z 255 m/z 239
0-
C. EasA_NI_F176Y + EasG + Chanoclavine-l-aldehyde + NADPH
100-
m/z 239 m/24
D. Agroclavine
100- m/z 239
E. Festuclavine
100m/z 241
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Figure 4.15. LC-MS chromatograms with selected ion monitoring comparing active
EasAAf_Y178F + EasG. Peak intensities for this set of chromatograms have been
normalized to allow relative comparison of compound masses present.
A. Selected ion monitoring at m/z 241. Festuclavine 11 [M+H]*= 241 was observed with
the active EasA Af Y178F mutant.
B. Selected ion monitoring at m/z 239. Agroclavine 10 [M+H]*= 239 was not observed.
Agroclavine Festuclavine
[M+H]* 239 [M+H]* 241
A. EasAAfY178F + EasG + Chanodavine-1-aldehyde + NADPH
B. EasA_Af_Y178F + EasG + Chanoclavine-I-aldehyde + NADPH100-
m/z 241
m/z 241
n/z 239
3 32 3....4 3 . . . . . ... 0ime
30 320 3.0 360 38 4006 4 .O'720 44 4- .60 4.80 50 K520 5.40 5.60 50 60
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Conclusion
This chapter describes the functional characterization of an EasA homologue from
N. lolii that functions as an isomerase, in contrast to the EasA from A. fumigatus in
Chapter 3, which acts as a reductase. The ability of EasA_Nl to produce agroclavine 10
in the presence of EasG allows us to propose an isomerase type mechanism for EasA_Nl
involving isomerization of the C8-C9 bond. However, details regarding the cyclized
iminium intermediate 8 resulting from the isomerization remain only speculative. Thus
far we propose that the NADPH iminium reductase EasG was capable of trapping the
intermediate from the EasA_Ni isomerization of the alkene of chanoclavine-I-aldehyde 7
to yield agroclavine 10 (Figure 4.1).
The production of agroclavine 10 by EasA_Nl in combination with EasG also
demonstrated that EasA homologues function with unique active site differences that
exert mechanistic control over the production of either festuclavine 11 or agroclavine 10
derived alkaloids at the branch point of ergot alkaloid biosynthesis. These findings also
demonstrated that chanoclavine-I-aldehyde 7 was the common pathway intermediate
prior to ergot alkaloid pathway divergence across different fungal species.
Our mutational analysis successfully showed that replacement of the
phenylalanine with tyrosine in EasA_NiF 1 76Y produced festuclavine 11 in addition to
agroclavine 10, thus engineering an additional reductase function into the wild type
EasA_Nl isomerase. This finding also substantiated that the tyrosine or phenylalanine
residue in the enzyme active site was a key mechanistic difference that defined a
reductase or isomerase type EasA in the production of either festuclavine 11 or
agroclavine 10 derived downstream ergot alkaloids. Other more subtle differences
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between these homologues that contribute to isomerase or reductase function will need to
be explored in future mutational analyses that extend beyond the active site residues. The
work presented in this chapter demonstrated that EasA homologues in divergent fungal
species were capable of having isomerase or reductase functions and gives precedence for
future experiments to explore the mechanistic details that govern ergoline ring D
formation.
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Chapter 5 . Role of Redox Enzymes Involved with the
Formation of Ergoline Ring C
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Introduction
Ergoline ring C formation, which starts from pathway intermediate N-Me-DMAT
4 to form chanoclavine-I 6, has been previously proposed to occur through two
successive oxidation steps (Figure 5.1). The occurrence of these two oxidation steps were
based on isotope feeding studies conducted by the Floss group.1, 2 These studies yielded
two important insights into ring C formation: (1) observation that a proposed diene
intermediate 5 was incorporated into downstream ergot alkaloids of C. purpureaI and (2)
molecular oxygen was incorporated into chanoclavine-I 6.2
Bioinformatics analysis of ergot biosynthetic gene clusters demonstrated that
easC and easE were two remaining functionally unassigned genes that encode for
enzymes capable of carrying out oxidation reactions. Notably easE and easC have
homologues in ergot gene clusters that were conserved across divergent fungal species,
signifying their likely involvement in the early steps of ergot alkaloid biosynthesis as
introduced in Chapter 1. The biosynthetic function of easC and easE had remained
speculative, although their protein sequence similarity to catalases and FAD oxygenases
suggested their likelihood to function in the cyclization of the ergoline ring C.
Gene disruption experiments described in Chapter 2, with the goal of assigning
function to EasC and EasE, demonstrated that knockout strains of AeasC and AeasE in A.
fumigatus failed to accumulate the downstream ergot alkaloids that were observed in the
wildtype. Instead, the knockout strains accumulated upstream pathway intermediate N-
Me-DMAT 4. It was also demonstrated that feeding chanoclavine-I 6 to AeasC strains
restored production of downstream ergot alkaloids. 3 In a separate study, Lorenz et al.
disrupted an easE gene homologue (ccsA) in Claviceps, which resulted in the
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accumulation of N-Me-DMAT 4 as a pathway intermediate with the loss of downstream
ergot alkaloids.4 Collectively, these findings demonstrated that gene disruption of easE or
easC accumulated the same pathway intermediate N-Me-DMAT 4, and suggested that
both gene products were required to observe the formation of ergoline ring C. However,
information regarding the mechanistic details of EasC or EasE catalyzed ring C
cyclization have yet to be established.
In this chapter, we describe our efforts to clone and characterize EasC and EasE
enzymes which are involved in the early steps of ergot alkaloid biosynthesis. This chapter
also describes the enzymatic preparation of the N-Me-DMAT 4 ergot pathway
intermediate to assay the activity of EasC and EasE. While conditions for expression of
easC and easE gene products were realized, we did not observe the production of
chanoclavine-I 6 from N-Me-DMAT 4. We followed this by an analysis of proposed
mechanisms of ring C formation and hypothesize whether other enzymes and conditions
may be required to study the functional role with EasC and EasE in vitro. Alternative
future approaches to reconcile how EasE and EasC may catalyze ergoline ring C
formation are described in Chapter 6.
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Figure 5.1. Proposed EasE and EasC mechanism for the cyclization of ergoline ring C to
form chanoclavine-I 6 from starting substrate N-Me-DMAT 4. Hypothetical
intermediates that have not been observed are shown in brackets.
H20Oxidase
EasE /
EasC ?
Epoxidation
s EasE /
EasC ?
CO2
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Experimental Methods
General materials and methods
General recombinant DNA cloning procedures were performed using pGEM-T
vector (Promega) propagated in E. coli Top10 (Invitrogen). Protein expression for A.
fumigatus EasE was conducted in DsbC SHuffle@ T7 Express Competent E. coli (New
England Biolabs). Protein expression for DmaW and EasC were conducted in E. coli BL-
21 (DE3) (Invitrogen). PCR amplification utilized Platinum Taq DNA Polymerase
(Invitrogen). Recombinant DNA plasmids were prepared using Qiaprep Spin Miniprep
and Qiaquick Gel Extraction kits (Qiagen). Restriction enzymes and T4 DNA ligase were
purchased from New England Biolabs. Primers for cloning were synthesized by
Integrated DNA Technologies and DNA sequencing was conducted by the MIT
Biopolymers Laboratory (Cambridge, MA).
For HPLC analysis the samples were chromatographed using a Hibar 250-4
LiChrosorb RP-Select B 5 pm column (Merck) with a mobile phase of acetonitrile/0. 1%
trifluoroacetic acid in water. LC-MS analysis was conducted on an Acquity Ultra
Performance BEH C 18 column (2.1 x 100 mm; 1.7 pm particle size) and eluted with an
acetonitrile/0. 1% formic acid water. Mass detection was conducted on a Micromass LCT
Premier TOF MS (Waters, Milford, MA) with an electrospray ionization source set in
positive mode.
Cloning and expression of C. purpurea dmaW
The C. purpurea dmaW gene was PCR amplified using primers designed based on
the nucleotide sequence of dma W from the NCBI database (AY259840) encoding the
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DmaW protein (AAP81209). The coding sequences were amplified from the C. purpurea
dmaW construct pKAES1 54 previously studied by Wang et al.5 A pair of oligonucleotide
primers were used to amplify the dma W gene: forward primer 5'- TT CATATG
GGTGTGTACGAAATTTTGAGTCTGA-3' (with NdeI restriction site in bold) and
reverse primer 5'-
GACTCGAGTTAAAGCTTCTTCGTTGAGAGTTCACAGCGCCGG-3' (XhoI
restriction site in bold). (Additional restriction sites were incorporated into the primers to
allow for cloning of dmaW as either an N-His6 or C-His6 construct.)
The PCR amplified dmaW gene was inserted into pGEM-T vector (Promega) for
propagation and sequencing. Subsequently, the dmaW sequence was excised from
pGEM-T by restriction digest and ligated into the NdeI/XhoI site of pET-28a(+)
(Novagen) expression vector as an N-His 6 construct. Expression was carried out in LB
media supplemented with kanamycin (50 pg/mL).
Optimal conditions for N-His6 tagged DmaW over expression were achieved at 5
pM IPTG and at 15 "C for 68 hours. The enzyme was purified by Ni-NTA affinity
chromatography where the purest fraction was obtained in elution buffer (100mM
imidazole, 20 mM Tris-HCl, 300 mM NaCl, and 10% (v:v) glycerol, pH = 8.0) (Figure
5.2). The purest DmaW fraction was collected and exchanged with dialysis buffer (50
mM Tris-HCl, 100 mM NaCl, 1 mM Dithiothreitol (DTT), 10% (v:v) glycerol, pH = 8.0).
Endpoint Assay of DmaW for production of DMAT 3 and N-Me-DMAT 4
The expressed and purified DmaW enzyme was assayed under previously
reported conditions (50 mM Tris-HCl, pH = 7.5, 5 mM CaCl2)6 ,7. The purified DmaW
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was assayed for prenylation of its natural substrate L-tryptophan 1 to produce 4-
dimethylallyltryptophan (DMAT) 3 by incubation of 0.6 pM DmaW with 1 mM
dimethylallyl pyrophosphate (DMAPP) 2 and 1 mM L-tryptophan 1 at room temperature
25 0C. DmaW was also tested for the prenylation of Na-Me-tryptophan (L-abrine) 26 by
incubation of 0.6 gM DmaW with 1 mM dimethylallyl pyrophosphate (DMAPP) and 1
mM L-abrine at room temperature 25 0C to produce N-Me-DMAT 4. Aliquots of the
enzyme assay were quenched with 10% trichloroacetic acid over time and subsequently
analyzed by HPLC and LC-MS.
For HPLC analysis, the samples were chromatographed with an acetonitrile/0. 1%
trifluoroacetic acid in water mobile phase (12:88 to 95:5 from 0-15 min, 95:5 to 12:88
from 15-23 min, at a constant flow rate of 1 mL/min) with the UV detection range set at
168-280 nm. For LC-MS analysis the samples were chromatographed with a linear
gradient (0.5 mL/min) of 20:80 to 80:20 (acetonitrile:0.1% formic acid water) over 5 min.
Cloning and expression of A.fumigatus easC
The A. fumigatus easC gene was PCR amplified using A. fumigatus cDNA. To
clone the desired gene, total RNA was extracted from A. fumigatus mycelia tissue using
the Trizol RNA extraction procedure (Invitrogen). Using Creator SMART MMLV
reverse transcriptase (Clontech), cDNA was constructed from the extracted total RNA.
Primers were designed based on the nucleotide sequence of easA from the NCBI database
(XM_751047). A pair of oligonucleotide primers were used to amplify the easC gene:
forward primer 5'- TT CCATGG GC CATATGCTAATTGAGCGTGGGTTATTGTC
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-3' (with NdeI restriction site in bold) and reverse primer 5'-TTCTCGAGTTAAGCTTT
GAGCCTGGAAAGAGAGACTTGTTTG-3' (XhoI restriction site in bold).
The PCR amplified easC gene was inserted into pGEM-T vector (Promega) for
propagation and sequencing. Subsequently, the easC sequence was excised from pGEM-
T by restriction digest and ligated into the NdeI/XhoI site of pET-28a(+) (Novagen)
expression vector as an N-His6 construct. Expression was carried out in LB media with
kanamycin (50 pig/mL), aminolevulinic acid (0.4 mM) and ferric ammonium sulfate (0.2
mM). E. coli BL-21(DE3) cells were grown to an OD 60 0 of 0.8 prior to induction with
IPTG (5 pM) and grown for an additional 68 hours at 15 *C prior to harvesting. EasC
enzyme was purified by Ni-NTA agarose (Qiagen).
Fractions containing pure EasC, as demonstrated by SDS-PAGE (Figure 5.5),
were collected and exchanged with dialysis buffer 50 mM Tris-HCl, 100 mM NaCl, 1
mM Dithiothreitol (DTT), 10% (v:v) glycerol, pH = 8.0. The final stock concentration of
EasC was at 0.1 mg/mL. The catalase assay was conducted in a quartz cuvette with 0.1
pM EasC with 10 mM H202 in dialysis buffer.
Cloning and expression of A.fumigatus easE
Starting with the reference sequence for EasE (XM_751049), an alternative
splicing of the easE gene was suggested by Dan Panaccione based on re-analysis
sequence alignments of EasE homologues in fungi and other FAD dependent
oxidoreductases. This newly assembled E. coli codon optimized EasE gene was
synthesized and ligated as an N-terminal His construct in pET28a(+) with restriction
sites in NdeI and EcoRI (Genscript). EasE was expressed using an E. coli strain that
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produces a disulfide bond isomerase (DsbC SHuffle@ T7 Express Competent E. coli,
New England Biolabs). Fractions containing pure EasE, as demonstrated by SDS-PAGE
(Figure 5.7), were collected and exchanged with dialysis buffer (50 mM K2HPO 4 , 100
mM NaCl, 10% (v/v) glycerol, pH = 7.0). Final holoenzyme stock concentration was at 6
pM. Analysis of the co-purified flavin of EasE was conducted with a UV-Vis
spectrophotometer.
Endpoint assay of EasC and EasE with N-Me-DMAT 4 substrate
DmaW (0.6 pM) was incubated with DMAPP (1 mM) and L-abrine (Na-methyl-
L-tryptophan) 26 (1 mM) for 2 hours to prepare the N-Me-DMAT 4 substrate. The
substrate 4 was then assayed with EasC (0.2 pM) and EasE (1.2 pM) under various
combinations of added H20 2 (10 mM), NADPH (500 pM), and Dithiothreitol (DTT) (20
mM) in 100 mM K2HPO 4 buffer (pH = 7.0) at 25*C for 60 min. Aliquots were quenched
by dilution in 0.1% formic acid in water and analyzed by LC-MS.
For LC-MS analysis, the samples were chromatographed using a gradient of
acetonitrile/0.1% formic acid in water mobile phase (10:90 to 20:80 from 0-5 min, 20:80
to 90:10 from 5-6 min, and 90:10 to 10:90 from 6-7 min at a constant flow rate of 0.5
mL/min). UV-Vis spectra were acquired on a Varian Cary 50 Bio Scanning
Spectrometer.
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Results and Discussion
Enzymatic preparation of pathway intermediate N-Me-DMAT 4
DmaW was successfully cloned, heterologously expressed, and purified by Ni-
NTA agarose to yield enzyme at 3.0 mg/L culture (Figure 5.2). The purified DmaW was
incubated with L-tryptophan 1 (1 mM) and DMAPP 2 (1 mM) and formation of DMAT 3
was observed using HPLC. Approximately 75% conversion of the starting substrate L-
tryptophan was observed after 3 hours (Figure 5.3A). DmaW enzymatic activity for the
prenylation of natural substrate L-tryptophan 1 was also observed by LC-MS analysis,
which indicated decrease of the [M+H]* 205 peak and accumulation of the [M+H]* 273
product peak (Figure 5.4). This activity shown by DmaW was consistent with the
function of this enzyme previously reported by Wang et al.5
Previous work by Steffan et al. also demonstrated that the DmaW homologue
from A. fumigatus could prenylate L-abrine 26 in addition to its natural substrate L-
tryptophan 1.9 Therefore, DmaW can potentially be used to generate the N-Me-DMAT 4
substrate needed to test EasE and EasC directly. DmaW was incubated with L-abrine 26
(1 mM) and DMAPP 2 (1 mM) and formation of N-Me-DMAT 4 was observed by
HPLC, giving approximately 59% conversion of the starting substrate L-abrine 26 in 3
hours (Figure 5.3B). DmaW enzyme activity was also observed by LC-MS by monitoring
the L-abrine 26 peak at [M+H]* 219 and observing the accumulation of a [M+H]* 287
peak corresponding to the expected mass of N-Me-DMAT 4 (Figure 5.3). The identity of
the N-Me-DMAT 4 product of DmaW prenylation of L-abrine 26 was further
substantiated as it shared an identical mass and retention time as the intermediates that
accumulated in the AeasC and AeasE A. fumigatus mutants as presented in Chapter 2
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(Table 2.1, Figure 2.5).3 The successful expression of DmaW allowed preparation of the
N-Me-DMAT 4 pathway intermediate required to assay EasE and EasC oxidases.
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Figure 5.2. SDS-PAGE gel of DmaW (expected size 52 kDa)
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*. NEB Broad Range Protein Ladder (2-212 kDa)
1. 50 mM Imidazole
2-9. 100 mM Imidazole
180
Figure 5.3. HPLC chromatogram of DmaW enzyme assayed with A. L-tryptophan 1 and
DMAPP 2 and B. L-abrine (Na-L-tryptophan) 26 and DMAPP 2 (Detector 168-280nm)
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Figure 5.4. LC-MS chromatograms of endpoint activity assay (1 hour reaction) for
purified DmaW dimethylallyl prenyltransferase. Peak intensities for this set of
chromatograms have been normalized to allow relative comparison of compound masses
present. A. L-tryptophan 1 and B. L-abrine (Na-Me-L-tryptophan) 26
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A. DmaW + DMAPP + L-Trp: Observed masses for L-tryptophan 1 [M+H]* = 205 and
product DMAT 3 [M+H]* = 273.
Boiled DmaW + DMAPP + L-Trp (negative control): Observed mass for L-tryptophan 1
[M+H]* = 205 only.
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B. DmaW + DMAPP + L-abrine: observed masses for L-abrine 26 [M+H]* = 219 and
product N-Me-DMAT 4 [M+H]* = 287.
Boiled DmaW + DMAPP+ L-abrine (negative control): observed mass for L-abrine 26
[M+H]* = 219 only.
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Expression and functional characterization of easC catalase
The easC gene was successfully cloned, yet initial expression attempts were low
yielding and did not display catalase activity when tested with H2 0 2 . Due to the protein
sequence homology of EasC to catalases, we added precursors ferric ammonium sulfate
(0.2 mM) and aminolevulinic acid (0.4 mM) previously reported to support heme
formation to our expression cultures. 10, 11
Under this new set of expression conditions, EasC was purified using Ni-NTA
agarose at a yield of 0.3 mg/L (Figure 5.5) culture and displayed catalase activity when
assayed with H20 2. The activity of EasC was determined by an assay for catalase
monitoring the decomposition of H2 0 2 with a spectrophotometer at 240 nM, as
previously reported. -4 The reaction mixture of EasC (0.1 pM) and H20 2 (10 mM) at
pH = 8.0 displayed a gradual decrease in absorbance intensity over time when compared
with the inactive boiled EasC control, which maintained a constant absorbance over the
same time interval (Figure 5.6). These observations supported the catalase functionality
expected for EasC.
To further characterize the functionality of EasC catalase relative to other known
enzymes with oxidase activity, a UV-visible spectrum of EasC (1.6 pM) at pH = 8.0 was
also taken from 250 nm to 550 nm, where the local maxima usually associated with heme
containing enzymes were observed at 277 nm and 412 nm (Figure 5.7). The absorbance
ratio of A4 06/A280 was determined to be 0.13. From previous studies, typical catalases
were observed with A4 06/A2 80 ratios closer to 1 while catalases that also exhibited
peroxidase activity had values less than 1.15,16 Therefore, EasC, as produced under these
expression conditions, was not completely reconstituted with heme.
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Figure 5.5. SDS-PAGE gel of EasC (Expected Size 59 kDa)
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Figure 5.6. EasC catalase activity for decomposition of H20 2 . Absorbance monitored by
spectrophotometer at 240 nm over a time course with 0.1 pM EasC + 10 mM H2 0 2.
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Figure 5.7. UV-Vis spectrum EasC (1.64 pM) local maxima at 277 nm and 412 nm.
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To test the idea that EasC was involved in chanoclavine-I 6 formation, EasC (0.2
[tM) was incubated with N-Me-DMAT 4 produced from incubating DmaW (0.6 piM)
with DMAPP 2 (1 mM) and L-abrine 26 (1 mM) for 2 hours. The assay was also
conducted with and without the addition of H20 2 (10 mM), but no downstream product
intermediates were detected by HPLC or LC-MS analysis.
These data demonstrated that EasC displayed only standard catalase activity,
which suggest that EasC may play a general protective role for the fungus from other
oxidative enzymes that generate H20 2 . To test this hypothesis, our collaborators in
the Panaccione lab conducted in vivo feeding studies of chanoclavine-I 6 to gene
disrupted cultures of easC, as described in Chapter 2. They observed that downstream
ergot alkaloid production was restored to similar levels as the dmaW gene disrupted
control culture upon feeding. This finding suggested that easC does not act solely as a
general protective enzyme to the fungus but provided a functional role in the cyclization
of ergoline ring C.3 Yet the exact role of EasC as a catalase with possible peroxidase
function in the cyclization of ring C remains speculative. Therefore, it was necessary to
assay EasC in combination with other relevant pathway enzymes, such as EasE of the
cluster, as described in the next section in order to investigate its potential as a peroxidase
in ring C formation.
Expression and functional characterization of EasE
Initial attempts to express the easE gene product in E. coli BL-21 (DE3) were
unsuccessful. More reasonable yields of EasE protein were obtained by using S.
cerevisiae as an expression host; however, EasE did not co-purify with any flavin co-
factor as evidenced by UV-Vis spectroscopy. Screening by assay of EasE in various
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conditions with combinations of added FMN (60 pM), FAD (30 pM), H2 0 2 (10 mM),
and EasC (0.2 jiM) protein did not display turnover of the N-Me-DMAT 4 substrate or
accumulate any discernable product when analyzed by LC-MS.
These findings led us to re-analyze the splicing sequence of the EasE gene with
other homologues in ergot producing gene clusters and retrial expression with an E. coli
codon optimized EasE sequence. Due to the cysteine rich protein sequence of EasE, we
also tried to further optimize the proper folding and expression of this protein by using an
E. coli strain that expressed a disulfide bond isomerase (DsbC SHuffle@ T7 Express
Competent E.coli, New England Biolabs).
Improved expression of EasE was realized after codon optimization and
expression in E. coli DsbC SHuffle@ and purification using Ni-NTA agarose yielded a
yellow colored protein at 1.2 mg/L of culture (Figure 5.8). When analyzed by UV-Vis
spectrometry, EasE exhibited the characteristic flavin profile (Figure 5.9). EasE was
denatured and precipitated by the addition of 0.2% SDS, leaving a yellow supernatant
that displayed the characteristic flavin spectra and was identified as flavin adenine
dinucleotide (FAD) by comparison with an authentic standard (Figure 5.9). Concentration
of the holoenzyme was calculated using the reported extinction co-efficient of FAD at
11,300 M~1 cm~1 at 450 nm.' 8
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Figure 5.8. SDS-PAGE of EasE (A. fumigatus) (64 kDa)
* 1 2 3 4 5 6 7 8 9 10 11 12
*. NEB Broad Range Protein Ladder (2-212 kDa)
1. crude lysate
2. debris
3. column flow through
4. buffer wash 10 mM imidazole
5. 25 mM imidazole
6-12. 50 mM imidazole
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Figure 5.9. UV-Vis spectra of EasEAf (300 nm to 600 nm)
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Subsequent assay of the holoenzyme EasE (1.2 pM) with substrate N-Me-DMAT
4 in different conditions and combinations with EasC (0.2 pM), NADPH (500 gM), and
H20 2 (10 mM) did not lead to decrease of the substrate or accumulation of an
intermediate. DTT (20 mM), which has been previously used as a synthetic reductant for
flavins,19-21 was also added to the assay in order to see if EasE with a reduced FAD would
exhibit activity; however, no substrate turnover was observed.
While EasC and EasE had good precedence for their involvement in the formation
of ring C, we were challenged by difficulties in reconstituting their activity in vitro for
the conversion of N-Me-DMAT 4 to chanoclavine-I 6. These results led us to speculate
on the functional role of EasC and EasE in terms of their mechanism and contribution to
ring C cyclization. These speculations serve as guided hypotheses toward characterizing
these enzymes in vitro.
Proposed mechanisms of ergoline ring C formation
The formation of chanoclavine-I 6, the immediate product of ring C cyclization,
from substrate N-Me-DMAT 4 required a net four electron oxidation, which is likely to
occur in two successive two electron oxidation steps.1, 22, 23 The proposed mechanism of
ring C cyclization was based on previous isotope feeding studies by the Floss group.
They demonstrated that the diene 5 was a stable pathway intermediate that was well
incorporated into downstream ergot alkaloids' and that the oxygen of chanoclavine-I 6 is
derived from molecular oxygen.2 Furthermore, data from our previous gene disruption
studies of easC and easE, as described in Chapter 2, suggested that N-Me-DMAT 4 was
the substrate for oxidation by EasC and EasE to form chanoclavine-I 6.3
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On the basis of these previous studies and our observations of the heterologously
expressed EasC catalase activity and the co-purification of EasE with bound FAD, we
explored mechanistic scenarios which could account for the challenges that need to be
addressed before EasE and EasC activity can be successfully reconstituted in vitro. We
proposed several schemes in which EasC and EasE may function to form ring C.
(1) EasC as a catalase with peroxidatic activity and EasE as a FAD oxidase
EasE may be involved with the direct oxidation of N-Me-DMAT 4 to form the
proposed diene 5 intermediate as the first oxidation step. Like other known flavin
oxidases, EasE may be able to carry out the direct oxidation of N-Me-DMAT 4. The
oxidation is proposed to occur via the transfer of a hydride from the substrate to the EasE
flavin with a concerted deprotonation by an active site general base (Figure 5.1OA).
Precedence for this type of reaction had been observed in FAD oxidoreductases berberine
bridge enzyme and isoamyl alcohol oxidase.
24
-
26
EasE shares regions of protein sequence homology to the berberine bridge
enzyme from Eschscholzia californica (California poppy) (Figure 5.10 B) which has been
well characterized in its conversion of (S)-reticuline to (S)-scoulerine. 24, 25 The proposed
set of residues in berberine bridge enzyme which have been reported to be linked
covalently to the FAD and involved in catalysis have identical or similar counterparts in
the A. fumigatus EasE sequence alignments (Figure 5.11).24,21
The proposed mechanism for the initial oxidation in berberine bridge enzyme was
reported to proceed via a concerted proton abstraction and hydride transfer to FAD
(Figure 5.101B). 24,27 In our proposed mechanism for EasE, we believe that the diene 5
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could be formed directly from N-Me-DMAT 4 in an analogous fashion (Figure 5.1OA).
The berberine bridge enzyme also generated H20 2 as a byproduct during re-oxidation of
FAD. Similarly, we can envision that EasE would also generate H20 2 by product.
Additionally, EasE also contained regions of protein sequence homology to
fungal enzyme isoamyl alcohol oxidase from Aspergillus oryzae (Figure 5.12).26 Isoamyl
alcohol oxidase (Mre) from A. oryzae has been reported previously to catalyze the
oxidation of isoamyl alcohol to isovaleraldehyde and shares homology to FAD dependent
oxidoreductases. 26,28 Unlike the berberine bridge enzyme, mechanistic details for isoamyl
alcohol oxidase have not been reported. Yet, based on the reaction catalyzed by isoamyl
alcohol oxidase, it seemed likely that this oxidation may proceed via deprotonation of the
alcohol along with the transfer of a hydride to the FAD of the enzyme (Figure 5.1OC).
The re-oxidation of the reduced FAD with molecular oxygen would generate H20 2 as a
byproduct.
We propose that the EasC catalase / peroxidase may decompose the H20 2
byproduct of the EasE reaction to water and oxygen or use it to activate the heme for
epoxidation of the diene 5 intermediate. 2 9 It has been observed previously that some
catalases demonstrate peroxidatic activity, where the first molecule of H20 2 activates the
heme iron in order to oxidize either a second molecule of H20 2 or organic compounds via
a paired electron transfer or through sequential one electron transfer steps.'
5
',29-33
Notably, EasC displayed protein sequence homology to S. cerevisiae catalase-A,
which demonstrates both peroxidatic and catalatic activity (Figure 5.13). In order to
facilitate ring C cyclization, we speculated that EasC may be involved with the
epoxidation of proposed intermediate diene 5 (Figure 5.1 diene 5 to chanoclavine-I 6).
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The heme may be activated by H20 2 generated as a byproduct from the EasE reaction or
other metabolic processes that reduce molecular oxygen 02.32,34, 3 This scenario would
be consistent with results from previous isotope feeding studies where incorporation of
molecular 02 into formation of the chanoclavine-I 6 was observed.2
Alternatively, EasE flavin may act only on the later pathway of ring C cyclization
serving as an epoxidase on the intermediate diene 5 prior to cyclization or the ring
(Figure 5.14).36 Enzymes capable of carrying out these reactions for the epoxidation of
alkenes have been previously identified and are observed to require NADPH.37 39
In this scenario EasC would function to hydroxylate the benzylic C10 position,
resulting in diene 5 formation. Subsequent epoxidation of the diene 5 by EasE would
yield chanoclavine-I 6 (Figure 5.14). It is also possible that EasC may just act as a
dedicated catalase to prevent undesired accumulation of H20 2 from the EasE reaction as
described in the following section.
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Figure 5.10. Comparison of proposed mechanisms for the FAD dependent oxidation of
A. N-Me-DMAT 4 to the diene 5 intermediate by A. fumigatus EasE
B. (S)-reticuline to (S)-scoulerine by K californica Berberine Bridge Enzyme 24
C. Isoamyl alcohol to isoveraldehyde by A. oryzae MreA Isoamyl Alcohol Oxidase
(Hypothetical mechanism based on our interpretation of reaction catalyzed by MreA 26, 28
no detailed mechanistic studies have been reported for this enzyme)
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Figure 5.11. The A fumigatus EasE and EcalifornicaBBE region proposed to interact
with FAD (positions 131 to 292) shares 31% protein sequence identity and 48%
similarity. Residues involved with covalent attachment of FAD to BBE were His 104 and
Cys 166 highlighted in green. These residues were identical in EasE.
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Figure 5.12. AoryzaeMreA and A_fumigatusEasE share approximately 39% protein
sequence identity and 56% similarity.
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Figure 5.13. Afumigatus EasC and ScerevisiaeCatalaseA protein sequence share
approximately 43% identity and 60% similarity. The majority of residues proposed to
interact with the heme in ScerevisiaecatalaseA (green) were conserved for
A-fumigatusEasC (green). The V1 11A ScerevisiaeCatalaseA mutant (pink) was
reported to have increase peroxidatic activity over catalase activity. 5 This residue was
not conserved in A-fumigatusEasC.
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Figure 5.14. Proposed mechanism for EasC catalyzing the hydroxylation of C10 position
of N-Me-DMAT 4 as the first oxidation step. EasE catalyzes the epoxidation of the diene
5 intermediate as the second oxidation step.
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(2) EasC as a catalase and EasE as a FAD oxidase catalyzing successive oxidations
Alternatively, it is also possible that EasE may catalyze both oxidations in ring C
cyclization (Figure 5.15). Numerous flavin dependent oxidases function to carry out
oxidations with the transfer of a hydride equivalent from the substrate.25, 26, 40 If EasE
were capable of carrying out the complete set of successive oxidations to cyclize ring C,
then we propose that EasE could likely generate this diene 5 intermediate by the direct
oxidation of N-Me-DMAT 4 (Figure 5.15).
Subsequently, the EasE flavin C(4a)-hydroperoxide intermediate, generated from
the reaction with reduced flavin and molecular oxygen*', could be used to form the
epoxide 27 from the diene 5 in order to catalyze the formation of ring C to make
chanoclavine-I-aldehyde 7 (Figure 5.15). Precedence for such a reaction has been
previously reported for FAD catalyzed epoxidations. 37, 42, 43 Whether EasE can carry out
this further epoxidation reaction continues to be a focus of our future research. There has
been precedence for a flavin enzyme to carry out such successive oxidations such as
lactate monooxygenase, that oxidizes lactate to pyruvate then to acetate; however, these
internal monooxygenases are rare.44
If EasE carried out both oxidation steps, then EasC would only act as a protective
enzyme to decompose the H20 2 byproduct in order to prevent undesired product
formation or damage to the enzymes. Scenarios in which FAD oxidases like EasE have a
partner catalase, like EasC, to act in such a protective role have been previously
reported.45' 46
From our assays described earlier we have observed that EasC and EasE together
or in isolation did not turnover N-Me-DMAT 4 to form the proposed diene 5 or
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chanoclavine-I 6 under our in vitro assay conditions. It remains a possibility that EasC
and EasE act as part of a biosynthetic complex with other pathway enzymes to contribute
to the initial formation of the diene 5, aspects of which will be explored in the next
section.
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Figure 5.15. Proposed mechanism for EasE catalyzing successive oxidations on substrate
N-Me-DMAT 4 and involvement of EasC in decomposing the H202 byproduct. A.
Illustrates the re-oxidation of the flavin by molecular oxygen generating H202 as a
byproduct for subsequent decomposition by EasC. B. Illustrates oxidation of the diene 5
intermediate by the flavin C(4a)-hydroperoxide intermediate resulting in the formation of
the epoxide 27 followed by cyclization to yield chanoclavine-I 6.
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(3) EasE and EasC function in a complex which may include other pathway enzymes
Assays of EasE and EasC, in combination, have yet to demonstrate the conversion
of N-Me-DMAT 4 to chanoclavine-I 6. This suggests that other enzymes within or
beyond the ergot alkaloid gene cluster may be involved in the cyclization of ring C. If
EasC and EasE alone prove insufficient to catalyze the cyclization, this will guide efforts
to search for other candidate oxidases that may support the formation of chanoclavine-I 6
from N-Me-DMAT 4. Yet, it remains a possibility that EasE and EasC need to be present
under strictly regulated ratios in order to observe cyclization of ring C. These ratios may
govern the formation of a functioning enzyme complex in order to observe ring C
cyclization from N-Me-DMAT 4 in vitro. It has been previously reported that successful
reconstitution of active biosynthetic pathways in vitro often require the presence of other
pathway enzymes in appropriate ratios in order to achieve product formation.4 7
Due to the oxidations that were proposed in this step, greater control of the assay
conditions may be necessary in order to reconstitute EasC and EasE function in vitro. In a
study of the epoxidation reaction carried out by heme-peroxidases Coprinus cinereus
peroxidase and myeloperoxidase, it had been reported that slow introduction of H20 2 into
assays were required to observe epoxidation by heme-peroxidase in vitro, otherwise the
accumulation of inactive intermediates were observed.35 If EasC acts as a heme
peroxidase to carry out the epoxidation of the diene 5, then the H20 2 may need to be
slowly introduced from a source, such as from the re-oxidation of the flavin EasE in order
to observe activity. Therefore, EasC and EasE may need to be properly reconstituted in a
biosynthetic complex in order to observe their proposed function for the cyclization of
ergoline ring C in vitro.
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These proposed mechanisms serve to guide our future efforts toward the
successful reconstitution of EasC and EasE activity for the in vitro cyclization of the
ergoline ring C. EasC and EasE will also be assayed in the presence of other pathway
enzymes that may facilitate their proposed function in the production of chanoclavine-I 6.
Alternative approaches to assay these enzymes for their involvement of ergoline ring C
formation will be discussed further in Chapter 6.
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Conclusions
This chapter describes our current progress in efforts to characterize the enzymes
of the ergot gene cluster that were necessary for the cyclization of ergoline ring C, which
produces chanoclavine-I 6 from N-Me-DMAT 4. We were able to express the active
DmaW prenyltransferase from C. purpurea5 successfully and demonstrate its prenylation
activity on the natural L-tryptophan 1 substrate in addition to L-abrine 26 substrate to
yield N-Me-DMAT 4. This allowed us to obtain the N-Me-DMAT 4 proposed substrate
for EasE and EasC enzymes required for the cyclization of ergoline ring C to produce
chanoclavine-I 6. While expression of EasC catalase was successful and demonstrated
activity for the decomposition of hydrogen peroxide, EasC did not display peroxidase
activity alone or in the presence of EasE with N-Me-DMAT 4. Likewise, our expressed
EasE enzyme that co-purified with a bound FAD did not convert N-Me-DMAT 4 to
product chanoclavine-I 6 when assayed alone or in various combinations with EasC.
Further analysis of possible mechanisms and sequences in which these two
enzymes would function to form ring C, allowed us to speculate on possible reasons why
enzymes when assayed in vitro do not display their proposed oxidase activities. It was
possible that EasC and EasE may function as an enzyme complex given the instability of
the proposed intermediates or reactivity of the diene 5 intermediate to the peroxides that
may be generated in the reaction. Alternative approaches to further evaluate the role of
EasE and EasC and conditions to achieve the cyclization of ergoline ring C in vitro will
be discussed in Chapter 6.
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Chapter 6 . Conclusions and Future Directions
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Conclusions
Chapter 2 described the in vivo approach toward the assignment of function to
clustered genes associated with ergot alkaloid biosynthesis in A. fumigatus. In
collaboration with the lab of Professor Daniel Panaccione we were able to confirm
through targeted gene disruption that dmaW (prenyl transferase) and easF (SAM
dependent N-methyltransferase) functioned as the first two enzymes of the ergot alkaloid
pathway that precede ergoline ring C and D cyclization as had been previously suggested
by feeding studies and in vitro characterization of DmaW and EasF enzymes. 1-4
Using this gene disruption strategy, we were able to identify A. fumigtatus genes
associated with the critical ergoline ring C and D cyclizations. Disruption of easE (FAD
dependent oxidoreductase) and easC (catalase) genes led to the accumulation of the
pathway intermediate N-Me-DMAT 4 which had been hypothesized to precede ring C
cyclization.5 Disruption of easA (Old Yellow Enzyme homologue) demonstrated the
accumulation of the pathway intermediate chanoclavine-I 6 and chanoclavine-I-aldehyde
7, pathway intermediates that were believe to precede ring D cyclization.6
This finding signified that easA plays a functional role in the cyclization of
ergoline ring D in festuclavine 11 derived alkaloids and suggested that it functions as a
reductase similar to Old Yellow Enzyme.7 Subsequent augmentation of the easA gene
with a homologue of easA from C. purpurea in vivo, resulted in a switch in the ergot
alkaloid profile of A. fumigatus toward agroclavine 10 derived products in contrast to
wild type A. fumigatus, which produces festuclavine 11 derived ergot alkaloids. This
suggested that the gene product EasA from C. purpurea functions as an isomerase to
catalyze ring D cyclization in agroclavine 10 derived ergot alkaloids.
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Importantly, these results demonstrated that EasA was an enzyme acting at the
critical branch point of ergot alkaloid biosynthesis across divergent fungal species,
leading to the production of either festuclavine 11 or agroclavine 10 derived compounds.
These in vivo gene disruption studies proved crucial to our efforts in understanding the
sequence of catalytic events that led to ergoline ring formation and the enzymes
associated with each step. These findings served as an essential guide toward our in vitro
study of the gene products involved in ergoline ring cyclization.
Chapter 3 described our functional characterization of the A. fumigatus EasA Old
Yellow Enzyme homologue in vitro. This study provided evidence that EasAAf
facilitates the reduction of the alkene in chanoclavine-I-aldehyde 7 catalyzes an
intramolecular cyclization to form ring D of the ergoline structure via an intermediate
cyclic iminium intermediate 9.8 Trapping the iminium intermediate 9 either by synthetic
reduction or by the addition of the NADPH dependent oxidoreductase EasG, also present
in the ergot cluster, demonstrated that the cyclic iminium intermediate 9 precedes
festuclavine 11 formation. These findings suggested that EasAAf and EasG together
catalyze the full set of transformations necessary to form ring D of festuclavine 11
starting from substrate chanoclavine-I-aldehyde 7. The successful in vitro
characterization of EasAAf correlated with the findings of the in vivo easA gene
disruption study, further substantiating that EasA functioned at the critical branch point
of ergot alkaloid biosynthesis. These findings provided the platform upon which more
detailed mechanistic studies can be performed to reconcile the mechanism and
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stereoselectivity of this critical ring D cyclization across ergot alkaloid producing fungal
species.
Chapter 4 described our functional characterization of the EasA Old Yellow
Enzyme homologue from N. lolii in vitro.9 The work described in this chapter
demonstrated that the function of the N. lolii EasA was uniquely different from A.
fumigatus EasA. EasANl, together with EasG, functioned to catalyze the set of
transformations necessary to form ring D of agroclavine 10 starting from the substrate
chanoclavine-I-aldehyde 7. This observation suggested that EasANl functioned with
isomerase activity as opposed to the reductase activity observed for EasAAf.
Significantly, this finding showed that both EasA homologues utilized the same pathway
intermediate chanoclavine-I-aldehyde 7, yet produced a downstream product that was
structurally different. EasAAf and EasG produce festuclavine 11 with a reduced C8-C9
bond, while EasANl and EasG retains a C8-C9 double bond yet in opposite geometrical
configuration relative to the starting substrate chanoclavine-I-aldehyde 7. These findings
reinforced the idea that EasA homologues are at the critical branch point of ergot alkaloid
biosynthesis across divergent fungal species.
Additionally, we obtained further insight into what mechanism governed this
difference in activity among EasA homologues by identification of an active site tyrosine
in EasAAf homologues associated with festuclavine 11 producers versus an active site
phenylalanine in EasANl homologues associated with agroclavine 10 producers (Figure
4.3). The EasANl_F176Y mutant demonstrated that the substitution of a tyrosine for
phenylalanine in the isomerase type EasA resulted in newly acquired reductase activity
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for the enzyme; therefore, the EasA_Ni_F176Y along with EasG could yield both
agroclavine 10 and festuclavine 11 from starting substrate chanoclavine-I-aldehyde 7.
These studies provided novel insight into the strategy easA homologues employ to
modulate reductase activity into isomerase activity and thereby establishing structural
diversity in ergot alkaloid biosynthesis. Findings from this study can be extended toward
other biosynthetic systems to identify enzymes which may catalyze analogous reductase
and isomerase reactions.
Chapter 5 described our efforts toward reconstitution of EasE and EasC enzymes
in vitro to study their functional roles in the cyclization of ergoline ring C. Progress was
made in establishing an enzymatic method for preparation of the N-Me-DMAT 4
substrate as well as for the expression of enzymes EasC with catalase activity and EasE
that co-purifies with FAD. However, EasE and EasC, under various assay conditions and
combinations, were not sufficient to catalyze the cyclization of N-Me-DMAT 4 to
produce pathway intermediate chanoclavine-I 6 in vitro. Analysis of possible
mechanisms of ring C cyclization by EasE and EasC, as well as the possible involvement
of additional pathway enzymes, allowed us to speculate on alternative approaches to
achieve reconstitution of these enzymes in vitro. These approaches of studying the
cyclization of ring C in vitro are further described in future directions.
214
Future Directions
Exploring active site differences that define reductase versus isomerase EasA
EasA Mutants to Probe Mechanism
Further detailed study into the mechanism of EasA will be essential for
understanding key active site differences that define a reductase or isomerase type
enzyme. EasAAf demonstrated the reduction of the C8-C9 carbon of substrate
chanoclavine-I-aldehyde 7, yet the contributions of other active site residues towards the
stereoselective cyclization of ring D remain to be elucidated. In the case of EasA_Nl,
isomerization of the C8-C9 double bond and stabilization of the proposed enolate
intermediate remains a point of research focus. These future studies on EasA will be
guided by the methods previously employed for the extensive enzyme characterization of
Old Yellow Enzyme and homologs.10-16
As introduced in Chapters 3 and 4, OYE shares a conserved set of mechanistically
important active site residues with EasA homologues. One approach will use site directed
mutants to detail the mechanistic contributions of proposed active site residues towards
the reductase or isomerase function of EasA. As a preliminary study, guided by protein
sequence alignments of EasAAf against S. carlsbergensis OYE (Figure 3.1), we made
mutations to active site residues such as EasAAf H173N and N176H. Based on the
previous studies of the OYE mechanism10 , we proposed that the identical EasAAf H173
and N 176 residues also acted as hydrogen bond donors to the carbonyl oxygen of
chanoclavine-I-aldehyde 7, facilitating transfer of the hydride from FMN to reduce the
C8-C9 double bond (Figure 3.4). However, the EasAAfH173N and EasAAfN176H
mutations did not abolish reductase activity or significantly alter the enzyme's selectivity
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toward production of the major cyclized iminium diastereoisomer 9, yet rates of
chanoclavine-I-aldehyde 7 substrate turnover were generally slower when compared to
the wild type. A double mutant consisting of mutations to EasA H173N and N176H,
however, did not show activity for the reduction of chanoclavine-I-aldehyde 7.
Collectively, these observations suggest that EasAAf H173N and N176H residues are
important contributors to the function of EasAAf, similar to the H191 and N 194
residues of OYE. To study these EasA mutants further, kinetic constants will be obtained
to detail the contributions of each of these mutations toward NADPH and chanoclavine-I-
aldehyde 7 binding. This preliminary study demonstrated that the S. carlsbergensis OYE
serves as a good model toward the future design and characterization of additional EasA
mutants. Recent work in the lab of Professor Audrey Lamb has resulted in a preliminary
crystal structure that will guide more extensive mutations of EasAAf to detail its
mechanism.
While we were successful in engineering additional reductase function into
isomerase Eas_Ni by a Fl 76Y substitution, it is still a challenge to switch the function of
EasAAf from reductase to isomerase. As discussed in Chapter 4, EasAAfY178F
demonstrated the same reductase function as the wild type enzyme, leading us to believe
that other active site residues may be contributing to EasA_Ni isomerization activity that
are not present in EasAAf. Such active site residues may, for example, preclude water
from donating a proton to a reaction intermediate. To explore these possibilities fully
with the ultimate goal of engineering isomerase function into the EasAAf reductase,
other mutations on EasAAf that extend beyond its active site will be necessary.
Similarly, we will also attempt to engineer the EasANl_F176Y mutant from Chapter 4,
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which exhibits both reductase and isomerase activity, to produce only the reductase
product. This may in turn identify residues that are critical for facilitating isomerase
function of EasANl.
Exploring the Stereochemistry of EasA Catalysis by Deuterium Labeling
Although many of the Old Yellow Enzymes previously discovered have
demonstrated their function to reduce the alkenes of ap-unsaturated aldehydes and
ketones on a variety of substrates, only a few studies have examined the stereoselectivity
of the alkene reduction. 17' 18 For S. carlsbergensis OYE, it has been proposed that the net
anti-addition of H2 across the alkene occurs via the transfer of hydride from flavin
followed by protonation of the alpha carbon by the active site tyrosine.1 o, 12, 19 It will be of
interest to study the stereoselectivity of EasAAf and EasA_Nl given that they are unique
OYE homologues which include an additional rotation step after hydride transfer in order
to form ergoline ring D.
An approach to yield further insight into the stereoselectivity of EasAAf
reductase and EasANl isomerase reactions will utilize deuterium labeled NADPH
(NADPD) to monitor the incorporation of the deuterium label into the enzyme product.
For EasAAf reductase, the incorporation and location of deuterium label in the
downstream product festuclavine 11 by NMR characterization, could yield information
on the stereoselectivity of the hydride transfer from the flavin to the C9 position of
chanoclavine-I-aldehyde 7 (Figure 6.1).
For EasANl, vital details into the mechanism of the isomerization could be
obtained by using NADPD and observing for the incorporation of the deuterium label
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into downstream product agroclavine 10. This would provide insight into the
stereoselectivity of both the hydride transfer and the proposed re-oxidation of the C8-C9
double bond via hydride transfer from the substrate C9 position back to flavin (Figure
6.2). The distribution of the deuterium label by EasANl isomerase into the agroclavine
10 product will be useful toward studying the proposed intermolecular transfer of the
hydrogen that has been previously proposed by the Floss group.20
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Figure 6.1. Proposed incorporation of deuterium label via NADPD during ergoline ring
D formation as an approach to explore the stereoselectivity of the proposed EasAAf
reductase and EasG.
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Figure 6.2. Proposed incorporation of deuterium label via NADPD into during ergoline
ring D formation as an approach to explore the stereoselectivity of the proposed EasA_Nl
isomerase and EasG.
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In a complementary approach, an assay of EasAAf or EasA_N1 in combination
with EasG and NADPH in D2 0 will also yield important mechanistic insight by
examining the incorporation of deuterium label from solvent. After the transfer of the
hydride from reduced flavin to the C9 position of chanoclavine-I-aldehyde 7, EasAAf
reductase reaction is believed to proceed with the donation of a proton (active site
tyrosine) to the C8 position, in contrast with the EasANl isomerase reaction which is
believed to proceed with no proton donation to the C8 position (active site
phenylalanine). Currently we believe that the EasAAf active site is more solvent
accessible due to the finding that the EasAAfY1 78F mutant was still able to carry out
the production of festuclavine 11, a reaction that is consistent with reductase EasA
activity. This set of experiments carried out in D2 0 could yield further information about
differences in the solvent accessibility for active sites of EasAAf and EasANl, and
mutants of these enzymes.
Kinetic Isotope Effects to Detail the Reductive and Oxidative Reactions of EasA Catalysis
Valuable details regarding the mechanism of the reductive and oxidative half
reactions of EasAAf and EasA_Nl enzymes will also be elucidated by the measurement
of kinetic isotope effects in assays with NADPD and H20 or D2 0.2 These kinetic
isotope effects would yield mechanistic insights into the details of the hydride transfer to
compare with those previously reported for other OYE homologues."' 14,22 Stopped flow
spectroscopy approaches that had been previously used for measuring the kinetic isotope
effects of the OYE homologue Morphinone Reductase, may be similarly applied to the
study of EasA.22
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The characteristic flavin absorption spectrum of EasA FMN will serve as a
spectroscopic handle to measure rates of the reductive half reaction with NADPH and the
oxidative half reaction of reduced FMN and substrate chanoclavine-I-aldehyde 7. This
approach will provide the ability to deconvolute the details of the proposed mechanism of
intermolecular hydrogen transfer with EasA_Nl and the isomerization of the C8-C9
chanoclavine-I-aldehyde 7 double bond (Figure 4.13A).2 Additionally, it will be
informative to contrast the flavin absorption spectra of EasAAf reductase with EasANl
isomerase, as they may display different populations of oxidized and reduced states of
flavin over time due to their proposed differences in mechanism.
As the kinetic isotope effect reveals greater mechanistic detail into the reductive
and oxidative half reactions characteristic of EasA and OYE homologues, another
interesting aspect of the reaction to study are the details of the hydrogen transfer between
the EasA flavin, NADPH, and chanoclavine-I-aldehyde 7 substrate. Previous studies on
OYE have proposed that the reactions proceed by hydride transfer, yet only a few studies
have addressed the possibility of a radical based mechanism.23-25 Based on these previous
studies, electron spin resonance (ESR) spectroscopy may be used to observe formation of
radical intermediates generated in the redox half reactions catalyzed by EasA. The
experimental setup will be guided by previous ESR studies that have been used to
observe radical formation in similar reactions catalyzed by OYE homologues. 23,25 , 26 This
approach will allow for observation of significant differences in the mechanism of
hydrogen transfer that may distinguish isomerase from reductase EasA.
It is necessary to yield greater mechanistic insight into EasA to understand the
strategy these enzymes employ to catalyze reductase or isomerase reactions. These
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strategies may well extend beyond the ergot alkaloid biosynthetic pathway given the
abundance of OYE homologues across different species. Furthermore, this knowledge is
also applicable toward the production or re-engineering of enzyme catalysts to carry out
isomerization or reduction of alkenes that are not easily accessible by conventional
synthetic approaches.
Exploring potential EasA and EasG interactions to form ergoline ring D
From Chapters 3 and 4, we observed that EasG NADPH reductase is important
for reduction of the cyclic iminium intermediate 9 to form either festuclavine 11
(EasAAf + EasG) or agroclavine 10 (EasA_Nl + EasG). The immediate product of
EasA_Af and EasA_Nl are proposed to be cyclic iminium intermediates 9 and 8
respectively, which seem prone to decomposition or adduct formation with nucleophilic
protein side chains. To prevent the formation of undesired byproducts or protein adducts,
we speculate that there may be a physical protein-protein interaction between EasA and
EasG that ensures efficient production of either festuclavine 11 or agroclavine 10
downstream products.
Preliminary experiments to demonstrate a physical interaction between EasA (42
kDa) and EasG (30 kDa) proteins would be to subject them to gel filtration
chromatography under various buffer conditions and concentrations or protein, substrate,
and co-factors. The elution profile of EasA and EasG together will be compared to the
profiles of these enzymes when analyzed separately, in order to observe if they associate
into a larger protein complex.27, 28 If results from gel filtration chromatography are
supportive of interactions of EasA and EasG, analytical ultracentrifugation will be used
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to look for additional evidence for protein-protein interactions. 29,30 In a complementary
study, yeast two hybrid3 1-33 or co-immunoprecipitation 34-3 6 approaches may be used to
examine interactions between EasA and EasG proteins. A crystal structure of this
complex will also be pursued to provide novel insight into how these proteins may work
together to facilitate either reductase or isomerase activity.
Reconstitution of EasE and EasC activity in vitro for ergoline ring C formation
While there is good evidence for the involvement of EasE and EasC in the
cyclization of ergoline ring C as introduced in Chapter 2, there are still challenges to meet
in order to reconstitute EasE and EasC activity in vitro as discussed in Chapter 5. While
EasC displayed catalase activity for decomposing H20 2, we speculate that we have been
unable to express EasE in its correct holoenzyme functional form. In Chapter 5, protein
sequence analysis comparing EasE to similar FAD dependent oxidases berberine bridge
enzyme and isoamyl alcohol oxidase suggested that FAD may be covalently linked to
EasE, as they share identical residues for covalent attachment of flavin. In light of this
observation, E. coli would not be an ideal host for expression of EasE, as the expression
of active Berberine Bridge Enzyme was only achieved in Pichia pastoris while
expression in E. coli yielded inactive protein.37 Moving expression of EasE from E. coli
into yeast such as Saccharomyces cerevisiae or Pichiapastoris seems to be a promising
approach toward realizing active holoenzyme EasE.
To obtain proper EasE and EasC activity in vitro, it is also necessary to determine
whether other enzymes in the ergot alkaloid cluster need to be present in order to observe
proper function of EasE and EasC or whether these enzymes function in a larger
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complex. One approach is to reconstitute the minimum set of genes necessary for
chanoclavine-I 6 biosynthesis in the closely related model organism Aspergillus nidulans,
which does not produce ergot alkaloids and has been previously used for the expression
of other A. fumigatus genes.3 8 A. nidulans is also an attractive host for expression of A.
fumigatus associated genes as they share a similar sporulation developmental pathway,
indicating that it is likely that native A. fumigatus promoters may be used successfully to
regulate the expression of their respective ergot pathway genes.39-4 1 Subsets of genes in
the ergot alkaloid cluster starting with the first four genes of the pathway DmaW, EasF,
EasC, and EasE would be transformed into A. nidulans to determine whether
chanoclavine-I 6 production occurs. If this minimal set of genes do not provide sufficient
evidence that chanoclavine-I 6 can be produced, additional ergot alkaloid genes of the
cluster may also be added. Even though these additional pathway genes may not be
directly associated with chanoclavine-I 6 biosynthesis, their presence may be required in
order to observe product formation. The presence or absence of additional pathway
associated genes and their relative ratios in polyketide biosynthesis have shown
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significant effects on product yield. The A. nidulans host would provide opportunities
toward achieving proper reconstitution and expression of the ergot pathway enzymes.
Reconstitution of chanoclavine-I 6 production in A. nidulans would indicate that
the minimal set of genes required for chanoclavine-I 6 biosynthesis are present.
Identifying this correct subset of genes will guide efforts toward the in vitro
reconstitution of EasC and EasE function, thus allowing for further characterization of
their functional role and mechanism in ergoline ring C cyclization.
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In Vivo Production of Novel Ergot Alkaloid Analogs
In vivo feeding studies with substituted tryptophan derivatives to A. fumigatus
culture will also be useful toward the production of novel ergot alkaloid analogs.
Preliminary feeding studies conducted with our collaborators in the Panaccione lab have
shown the incorporation of deuterated tryptophan from culture media into ergot alkaloids
of A. fumigatus, yet fluorinated tryptophan analogs remain difficult to incorporate into
downstream ergot alkaloids, most likely because of the high substrate specificity of
DmaW.
From previous studies the first committed step to ergot alkaloid biosynthesis in A.
fumigatus DmaW prenyltransferase is the pathway bottleneck for incorporation of
substituted tryptophan analogs.2 Expanding the substrate scope of this DmaW
prenyltransferase by rational reengineering using the recently published crystal
structure4 3 as a model will be a useful approach toward studying the incorporation of
other substrates into the downstream enzymes. Complementation of mutant DmaW with
expanded substrate scope into the AdmaW strain of A. fumigatus may allow for the uptake
of tryptophan derivatives that could be further incorporated into downstream enzymes to
produce unique analogs of ergot alkaloids, and additionally serve as an entryway toward
studying the substrate specificity of downstream ergot alkaloid pathway enzymes.
Furthermore, a similar strategy could also be used to complement alleles for genes
such as easA from a different species origin to study their function in the presence of
other ergot alkaloid pathway enzymes. In a parallel approach, the successful
reconstitution of the minimal set of genes for ergot alkaloid biosynthesis in a more
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tractable A. nidulans host will also allow us to gain a better perspective on the in vivo
production of novel ergot alkaloid derivatives.
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